Focal epilepsy, mode (most common among epilepsy diagnosis)

FE_MODE

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %3453, %345[4-5], %G40[0-2] Registry filters: Hospital discharge: ICD-10 — G40.0, G40.1, G40.2 Hospital discharge: ICD-9 — %345[4-5] Hospital discharge: ICD-8 — %3453 Cause of death: ICD-10 — G40.0, G40.1, G40.2 Cause of death: ICD-9 — %345[4-5] Cause of death: ICD-8 — %3453 2 out of 7 registries used, show all original rules.	8780
4. Check minimum number of events None	8780
5. Include endpoints None	8780
6. Filter based on genotype QC (FinnGen only)	8528

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze: DF11

NAME	FE_MODE
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%G40[0-2]
HD_ICD_9	%345[4-5]
HD_ICD_8	%3453
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%G40[0-2]
COD_ICD_9	%345[4-5]
COD_ICD_8	%3453
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy, mode (most common among epilepsy diagnosis) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	8528	4246	4282
Unadjusted period prevalence (%)	1.73	1.51	1.96
Median age at first event (years)	54.39	49.63	59.12

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8780: Matched controls
87763

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5054.0

307.7

929

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

12405.1

307.7

1099

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

166.0

307.7

163

N03AF01

ATC

carbamazepine; oral, rectal

20.2

307.7

2159

1395

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

307.7

446

G41.9

ICD-10 Finland

Status epilepticus, unspecified

127.9

307.7

438

R56.8

ICD-10 Finland

Other and unspecified convulsions

42.0

307.7

3264

1218

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

16384.0

307.7

3242

N03AG01

ATC

valproic acid; systemic, rectal

26.6

307.7

2975

1659

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

15.0

307.7

297

204

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

17.4

307.7

418

251

N03AX14

ATC

levetiracetam; systemic

257.3

307.7

3495

225

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

3328

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

+∞

307.7

1549

N03AX11

ATC

topiramate; oral

8.9

307.7

569

681

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

307.7

1104

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

307.7

2366

8630

AA1AD

NOMESCO Finland

CT of head and brain

5.2

307.7

4459

14535

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3287.9

307.7

633

N03AX18

ATC

lacosamide; systemic

1128.4

307.7

1088

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

8.0

307.7

2124

3377

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

4703.3

307.7

457

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.4

307.7

1709

3777

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

98.6

307.7

240

N03AB02

ATC

phenytoin; systemic

60.5

307.7

692

124

XA400

NOMESCO Finland

EEG

22.4

307.7

238

109

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.2

307.7

1417

3134

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.8

307.7

1404

4181

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

46.7

307.7

654

151

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

32.0

307.7

264

N88

ICPC

Epilepsy

807.1

307.7

603

N05BA01

ATC

diazepam; systemic, rectal

3.6

307.7

1826

5977

G40

ICD-10 Finland

Epilepsy

1201.9

307.7

868

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

3801

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

307.7

410

N05BA09

ATC

clobazam; oral

402.8

307.7

772

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.6

307.7

1465

4574

G40.9

ICD-10 Finland

Epilepsy, unspecified

1682.6

307.7

3138

G40.89

ICD-10 Finland

Other epilepsy

3512.2

307.7

348

XA800

NOMESCO Finland

Neuropsychological investigation

8.3

307.7

1120

1517

G40.10

ICD-10 Finland

Simple partial seizures

12809.6

307.7

1130

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

3393.8

307.7

337

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

18.3

307.7

501

289

N03AX23

ATC

brivaracetam; systemic

+∞

307.7

318

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

14854.7

307.7

1283

N05CD08

ATC

midazolam; nasal, systemic

10.7

307.7

649

648

L01AX03

ATC

temozolomide; systemic

50.3

307.7

499

105

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.9

307.7

804

978

N03AX15

ATC

zonisamide; oral

71.2

307.7

229

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

307.7

329

N03AF02

ATC

oxcarbazepine; oral

183.4

307.7

3754

356

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

42.2

307.7

384

N03AX09

ATC

lamotrigine; oral

9.0

307.7

1247

1584

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

7272

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

11.6

307.7

586

538

ZXC95

NOMESCO Finland

Use of surgical navigator

11.8

307.7

344

303

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

95.8

307.4

160

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

10.6

303.1

336

328

H02AB02

ATC

dexamethasone; systemic

3.2

294.7

1381

4899

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

289.6

1126

3561

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

13.9

287.8

267

197

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.6

279.2

1952

8565

N03AE01

ATC

clonazepam; systemic

4.0

271.1

825

2206

7803A

ICD-9 Finland

General symptoms, Convulsions

13.2

271.0

259

201

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

8.8

268.8

343

404

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.6

266.8

674

1565

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.5

264.4

294

288

K90

ICPC

Stroke/cerebrovascular accident

5.7

263.3

508

935

G41.2

ICD-10 Finland

Complex partial status epilepticus

112.5

259.9

133

R55

ICD-10 Finland

Syncope and collapse

2.9

257.0

1368

5191

Z2445

NOMESCO Finland

Psychologist

4.4

249.9

663

1598

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

6.3

245.8

425

703

N03AX22

ATC

perampanel; oral

2257.7

238.4

230

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

15.0

237.5

211

144

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

102.2

234.0

121

T90.5

ICD-10 Finland

Sequelae of intracranial injury

9.6

230.8

275

296

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1131.9

226.9

221

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.8

223.7

420

752

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

84.7

221.2

117

H53.4

ICD-10 Finland

Visual field defects

6.2

219.4

383

639

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

74.1

217.2

117

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

33.4

216.1

138

R4150

NOMESCO Finland

Neuropsychological rehabilitation

12.7

213.9

209

168

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

14.1

211.6

194

140

R41.0

ICD-10 Finland

Disorientation, unspecified

4.9

211.1

483

1031

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

76.3

210.6

113

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

210.2

201

N07

ICPC

Convulsion/seizure

37.1

206.5

128

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

1934.1

205.8

199

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

10.9

203.3

220

207

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

202.8

194

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.7

202.3

487

1084

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

7.7

201.5

287

385

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

197.9

1111

4304

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

24.9

191.9

135

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

189.2

181

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.8

187.1

298

452

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

187.1

179

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.3

186.1

1709

8335

130

Kela drug reimbursment

Malignant tumour

2.8

183.1

1018

3916

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.9

182.0

196

183

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.0

179.7

540

1422

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.5

179.1

214

231

N18

ICPC

Paralysis/weakness

5.7

176.1

332

596

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.4

175.3

296

477

TAB00

NOMESCO Finland

Lumbar puncture

3.7

175.1

589

1677

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

16.3

172.2

146

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

9.5

170.8

204

220

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

6.7

170.8

276

425

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

168.2

161

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.9

164.3

2910

18004

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

33.2

164.2

105

ZXC40

NOMESCO Finland

Use of ultrasound

10.5

158.0

175

170

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

155.2

735

2582

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

22.5

151.7

111

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

151.5

145

S06.3

ICD-10 Finland

Focal brain injury

6.8

150.9

238

357

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

9.2

147.9

180

199

N03AG04

ATC

vigabatrin; oral

+∞

144.1

138

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.7

142.5

849

3366

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

141.2

2373

14298

A28

ICPC

Limited function/disability NOS

2.1

140.6

1629

8620

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

13.4

139.8

132

100

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

14.7

137.3

123

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

7.7

137.1

193

255

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

49.8

136.6

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

7.1

135.5

205

294

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

1334.0

134.7

131

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.6

134.5

471

1374

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

54.7

133.9

G41.0

ICD-10 Finland

Grand mal status epilepticus

156.8

131.7

139

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.1

131.6

284

575

N03AF04

ATC

eslicarbazepine; oral

+∞

130.5

125

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.6

129.4

247

448

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

25.0

126.7

N05AX08

ATC

risperidone; systemic

2.5

126.1

873

3714

R4120

NOMESCO Finland

Occupational therapy

2.7

125.7

706

2710

WX892

NOMESCO Finland

Monitored bed care

2.6

125.4

805

3304

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.6

122.7

429

1249

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

1204.8

122.2

119

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.6

122.0

771

3139

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

36.5

122.0

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

247.3

119.2

122

R51.80

ICD-10 Finland

Headache

2.0

115.9

1441

7773

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

8.4

115.3

151

183

AAK00

NOMESCO Finland

Cranioplasty

39.2

114.4

S06.0

ICD-10 Finland

Concussion

2.2

114.2

1085

5283

ZX050

NOMESCO Finland

Stereotactic radiotherapy

7.7

111.3

157

208

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

109.6

105

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

109.6

105

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

+∞

106.4

102

R53

ICD-10 Finland

Malaise and fatigue

1.8

105.5

2138

13453

WX882

NOMESCO Finland

High dependency care

3.4

105.4

390

1177

N06AB04

ATC

citalopram; systemic

1.8

103.6

1797

10785

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.5

103.4

724

3087

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.9

102.3

306

800

K91

ICPC

Cerebrovascular disease

5.4

102.3

204

385

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

102.3

Z51.5

ICD-10 Finland

Palliative care

2.4

101.2

767

3388

N74

ICPC

Malignant neoplasm nervous system

39.0

101.2

AAF00

NOMESCO Finland

Ventriculostomy

9.6

100.9

119

126

SPAT1229

SPAT

Assessment of need for aid

2.4

100.5

753

3309

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

99.4

3836

28491

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.7

99.0

139

183

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

11.3

98.4

103

R42

ICD-10 Finland

Dizziness and giddiness

1.8

98.4

1959

12227

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.7

96.8

154

233

N28

ICPC

Limited function/disability (N)

4.7

96.5

225

486

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.4

96.3

190

355

W19

ICD-10 Finland

Unspecified fall

2.2

96.3

954

4706

F05.9

ICD-10 Finland

Delirium, unspecified

4.1

94.6

264

656

XF400

NOMESCO Finland

ECG with 12 standard connections

1.9

94.5

1447

8324

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

16.1

94.1

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

240.0

92.7

N05AH04

ATC

quetiapine; oral

1.8

92.2

1549

9169

SPAT1216

SPAT

Assessment of functional ability

1.9

91.8

1353

7681

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.4

90.2

342

1047

G41.8

ICD-10 Finland

Other status epilepticus

39.5

90.0

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

89.6

593

2459

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

89.5

1138

6145

L28

ICPC

Limited function/disability (L)

1.8

88.4

1504

8926

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

6.2

88.1

152

250

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.2

87.7

106

116

R4130

NOMESCO Finland

Speech therapy

3.5

87.6

303

875

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

11.7

85.9

A04AA02

ATC

granisetron; systemic, transdermal

2.5

84.5

583

2463

N05BA04

ATC

oxazepam; oral

1.7

84.3

2150

14273

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

20.5

82.8

N76

ICPC

Neoplasm nervous system unspecified

29.1

82.4

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

26.8

81.7

AA5PD

NOMESCO Finland

CT examination of brain pefusion

6.3

80.9

136

218

A06AD11

ATC

lactulose; oral

1.8

80.6

1285

7455

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

80.5

1375

8148

XX3DW

NOMESCO Finland

Time consuming IT work

2.0

80.4

932

4860

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

80.3

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

80.3

XCK00

NOMESCO Finland

Perimetry

2.4

80.2

599

2621

WX730

NOMESCO Finland

Conventional respirator

4.5

80.2

198

448

N02AA05

ATC

oxycodone; systemic

1.8

79.7

1467

8886

WX872

NOMESCO Finland

Intensive care

2.6

79.7

497

2001

N29

ICPC

Neurological sympt/complt other

3.9

79.3

239

628

R40.2

ICD-10 Finland

Coma, unspecified

6.3

79.2

134

216

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

27.1

79.1

PA6AD

NOMESCO Finland

CT of neck arteries

3.3

78.4

308

964

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

78.2

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

77.6

1296

7621

S01.0

ICD-10 Finland

Open wound of scalp

2.2

77.3

740

3590

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

77.3

1754

11256

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

76.6

1173

6712

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

76.3

539

2299

S06.2

ICD-10 Finland

Diffuse brain injury

5.5

75.3

147

272

Z2446

NOMESCO Finland

Social worker

2.2

75.2

648

3013

N19

ICPC

Speech disorder

4.1

75.0

207

510

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.0

74.8

161

325

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.0

74.5

216

552

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

10.1

74.3

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

74.0

WF002

NOMESCO Finland

Radical radiotherapy

2.4

74.0

516

2188

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.7

73.6

411

1565

SPAT1234

SPAT

Support of social functional capacity

2.5

73.6

501

2101

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

70.8

901

4844

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

8.9

70.7

100

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

10.3

70.2

A86

ICD-10 Finland

Unspecified viral encephalitis

8.4

70.2

109

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

69.7

430

1720

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

69.4

1808

11981

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

16.0

69.2

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

181.4

69.1

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.1

68.0

143

283

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

67.8

451

1870

PA2AD

NOMESCO Finland

CT angiography of brain

6.0

67.5

119

200

H47.2

ICD-10 Finland

Optic atrophy

8.7

65.8

TKC20

NOMESCO Finland

Catheterisation of bladder

2.2

65.8

625

3017

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.9

65.0

144

298

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

4.0

65.0

189

484

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.2

64.9

591

2805

N05AH03

ATC

olanzapine; systemic

2.3

64.8

547

2517

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

63.4

1092

6453

R56.0

ICD-10 Finland

Febrile convulsions

8.0

63.3

109

R1260

NOMESCO Finland

Evaluation of communicative skills

3.8

63.2

193

512

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

7.4

62.5

122

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

62.4

938

5316

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

17.1

61.7

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

61.5

SPAT1254

SPAT

Administration of medicine

1.7

61.1

1275

7947

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

11.1

60.5

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

60.5

ZXD05

NOMESCO Finland

Urgent procedure

1.5

59.7

2454

17950

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.1

58.9

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

58.8

1437

9326

AAA10

NOMESCO Finland

Biopsy through craniotomy

25.7

58.8

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.8

58.2

180

482

P20

ICPC

Memory disturbance

1.8

58.1

1054

6311

C03CA01

ATC

furosemide; systemic

1.5

58.0

2352

17136

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.0

57.9

695

3652

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.8

57.7

307

1140

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

8.2

57.6

N03AX25

ATC

cenobamate; oral

+∞

57.3

SPAT1301

SPAT

No procedures

1.5

56.9

2506

18552

N05CF01

ATC

zopiclone; oral

1.5

56.8

2497

18480

N99

ICPC

Neurological disease other

4.3

56.4

146

343

F80.1

ICD-10 Finland

Expressive language disorder

4.5

55.3

134

299

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

13.5

54.4

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.5

54.4

132

295

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

54.2

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.6

53.4

323

1279

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

53.4

1528

10283

G91.1

ICD-10 Finland

Obstructive hydrocephalus

8.0

53.1

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

53.1

432

1956

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

8.9

53.1

N06AX11

ATC

mirtazapine; oral

1.5

53.0

2590

19512

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

84.9

52.9

2152

FHL

Extraction, big brain

15.4

52.8

ZXY02

NOMESCO Finland

Neuropsychologist

6.4

52.7

137

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.7

52.3

121

260

ZXM40

NOMESCO Finland

Use of fluorescent substance

17.3

52.3

2161

FHL

Neck ligation, big brain

9.6

52.1

N03AG06

ATC

tiagabine; oral

510.8

51.5

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

15.8

51.1

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

+∞

51.1

M03BX01

ATC

baclofen; systemic

3.4

50.8

189

572

N06AB10

ATC

escitalopram; oral

1.6

50.5

1560

10669

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

19.6

50.2

S06.4

ICD-10 Finland

Epidural haemorrhage

14.0

50.1

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

256.8

50.1

Z3231

NOMESCO Finland

Registered nurse

1.5

50.0

2198

16186

3453A

ICD-9 Finland

Epilepsy, Grand mal status

490.5

49.4

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

79.1

48.9

R1250

NOMESCO Finland

Evaluation of functional capability

3.0

48.8

220

747

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.0

48.7

581

3043

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

16.5

48.7

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

7.4

48.6

R41.3

ICD-10 Finland

Other amnesia

2.7

48.5

268

1015

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.7

48.4

153

416

N02BE01

ATC

paracetamol; systemic, rectal

1.5

47.8

7242

66250

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

11.4

47.3

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

46.9

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

16.1

46.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

46.3

1158

7521

B01AC04

ATC

clopidogrel; oral

1.6

46.0

1248

8265

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

14.7

45.9

B01AA03

ATC

warfarin; systemic

1.5

45.7

1500

10371

N05CD07

ATC

temazepam; oral

1.7

45.7

883

5363

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

45.6

186

596

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.5

45.4

303

1257

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

44.9

1727

12342

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.5

44.9

289

1179

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

44.3

373

1712

G81.1

ICD-10 Finland

Spastic hemiplegia

13.2

44.2

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

44.0

1030

6575

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

82.2

43.9

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

9.2

43.8

1541, ,

Kela drug reimbursment

+∞

43.8

3069, ,

Kela drug reimbursment

+∞

43.8

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

6.6

43.6

107

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

11.0

43.2

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

10.5

42.8

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

150.7

42.8

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.8

42.5

642

3629

P85

ICPC

Mental retardation

9.0

42.4

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

55.8

42.4

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.8

42.2

131

352

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

419.5

42.2

N03AX12

ATC

[U] gabapentin; oral

1.6

42.1

1210

8110

N05BA06

ATC

lorazepam; systemic, sublingual

2.1

41.9

409

1990

N05AA02

ATC

levomepromazine; systemic

2.3

41.8

326

1449

I63.8

ICD-10 Finland

Other cerebral infarction

4.3

41.8

109

258

G72.8

ICD-10 Finland

Other specified myopathies

3.4

41.7

153

459

R50.9

ICD-10 Finland

Fever, unspecified

1.6

41.5

1207

8111

A04AA01

ATC

ondansetron; systemic, rectal

1.8

41.4

607

3397

R11

ICD-10 Finland

Nausea and vomiting

1.8

41.4

699

4082

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

54.7

41.4

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

7.9

41.2

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.8

41.2

687

3997

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

210.9

40.9

D32.03

ICD-10 Finland

Benign meningioma in ventricles

15.1

40.8

G40.8

ICD-10 Finland

Other epilepsy

+∞

40.6

G40.59

ICD-10 Finland

Other special epileptic syndromes

+∞

40.6

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

40.6

N05AD01

ATC

haloperidol; systemic

2.5

40.2

266

1099

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.5

39.9

101

OAB43, ,

SPAT

0.6

39.9

1040

15319

F83

ICD-10 Finland

Mixed specific developmental disorders

4.8

39.8

190

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

39.4

1975

14798

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

39.4

500

2671

A02BC02

ATC

pantoprazole; systemic

1.4

39.3

5214

45617

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

15.5

39.1

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.7

38.9

209

780

H02AB09

ATC

hydrocortisone; systemic

2.6

38.9

230

901

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

38.6

2684

21259

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

38.6

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

38.5

701

4181

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

38.3

199

730

RS222, ,

NOMESCO Finland

3.6

38.0

128

364

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

37.9

2072

15752

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

7.1

37.6

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.5

37.4

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

368.9

37.0

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

36.9

328

1539

Z3226

NOMESCO Finland

Physiotherapist

1.5

36.7

1378

9755

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.8

36.7

191

702

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.1

36.6

241

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

9.8

36.5

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

36.5

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.1

36.0

244

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

8.3

35.9

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.9

35.8

493

2703

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.2

35.6

293

1332

R4110

NOMESCO Finland

Physiotherapy

1.4

35.5

2039

15607

34519

ICD-8 Finland

Epilepsy, Generalisata convulsiva NUD

+∞

35.4

-, ,

ICD-10 Finland

2.7

35.4

198

755

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

35.2

334

1608

SPAT1240

SPAT

Therapeutic discussion

1.7

35.1

776

4870

SPAT1053

SPAT

Memory test

1.6

34.9

1023

6867

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

34.9

2306

18052

B01AC07

ATC

dipyridamole; systemic

2.1

34.9

358

1775

A04

ICPC

Weakness/tiredness general

1.5

34.9

1132

7771

G83.8

ICD-10 Finland

Other specified paralytic syndromes

14.0

34.7

R25.2

ICD-10 Finland

Cramp and spasm

2.6

34.5

204

800

N03AX16

ATC

[U] pregabalin

1.4

34.5

1668

12380

R25.1

ICD-10 Finland

Tremor, unspecified

2.3

34.3

254

1104

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

57.4

34.2

H53.2

ICD-10 Finland

Diplopia

2.3

34.1

261

1151

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

34.1

1455

10548

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

12.2

34.1

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

34.0

331

1609

G93.0

ICD-10 Finland

Cerebral cysts

6.1

34.0

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

50.2

33.4

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

3.0

33.1

145

485

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

7.1

33.0

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

48.9

32.5

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.8

32.3

472

2636

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

32.3

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

+∞

32.3

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

13.0

32.2

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

32.2

116

345

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.3

32.2

191

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.0

32.0

353

1796

Z02.4

ICD-10 Finland

Examination for driving licence

0.7

32.0

1087

15258

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

31.9

296

1412

SPAT1252

SPAT

Overall medication plan or its review

1.8

31.8

499

2847

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

6.1

31.8

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.4

31.7

215

900

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

11.9

31.6

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.1

31.3

296

1423

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

9.8

31.2

I61

ICD-10 Finland

Intracerebral haemorrhage

11.0

31.1

F03

ICD-10 Finland

Unspecified dementia

2.1

31.1

314

1548

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

31.0

985

6722

G41.1

ICD-10 Finland

Petit mal status epilepticus

42.3

30.8

WYA20

NOMESCO Finland

Home visit

2.8

30.7

157

572

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

160.5

30.7

Z75.5

ICD-10 Finland

Holiday relief care

4.0

30.2

209

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

30.2

GBB00

NOMESCO Finland

Tracheostomy

3.5

30.1

105

306

OAA67, ,

SPAT

0.5

29.9

391

6903

F05.8

ICD-10 Finland

Other delirium

4.1

29.6

195

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.3

29.4

113

350

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

30.1

29.4

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.6

29.3

151

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

29.3

817

5415

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

8.6

29.2

S22.3

ICD-10 Finland

Fracture of rib

1.7

29.2

526

3123

3450A

ICD-9 Finland

Epilepsy, Generalised nonconvulsive epilepsy

+∞

29.2

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.6

29.1

152

A29

ICPC

General symptom/complaint other

1.5

29.0

909

6178

S42.2

ICD-10 Finland

Fracture of upper end of humerus

1.9

28.9

344

1798

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

292.8

28.8

ZXD35

NOMESCO Finland

Usual procedure

2.2

28.8

255

1196

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

28.4

2694

22116

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

28.1

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

28.1

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

27.9

999

6977

Q85.1

ICD-10 Finland

Tuberous sclerosis

64.2

27.9

G45.4

ICD-10 Finland

Transient global amnesia

2.5

27.9

178

725

F10.25

ICD-10 Finland

Alcohol dependence continuous use

2.8

27.7

140

507

S02.11

ICD-10 Finland

Fracture of base of skull, open

6.3

27.7

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

9.0

27.7

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.5

27.6

265

TPH07

NOMESCO Finland

Cathetrisation of artery

1.5

27.5

810

5430

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.4

27.5

184

766

Y86

ICD-10 Finland

Sequelae of other accidents

5.6

27.5

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

27.2

125

430

B01AB05

ATC

enoxaparin; parenteral

1.3

27.2

2191

17555

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

27.1

537

3270

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

53.5

27.1

RS221, ,

NOMESCO Finland

2.9

27.1

130

458

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

7.4

27.1

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.5

27.1

167

669

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2.1

26.9

261

1267

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

24.7

26.5

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

34.1

26.4

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

4.3

26.4

160

R40.0

ICD-10 Finland

Somnolence

5.7

26.4

JN4AD

NOMESCO Finland

Body CT examination

1.6

26.3

701

4594

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.8

26.3

213

ZY010

NOMESCO Finland

Hospital outpatient

1.8

26.0

385

2159

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.9

25.9

323

1714

F44.5

ICD-10 Finland

Dissociative convulsions

72.8

25.8

C08CA01

ATC

amlodipine; oral

1.3

25.7

2671

22125

E87.6

ICD-10 Finland

Hypokalaemia

2.1

25.6

240

1150

H03AA01

ATC

levothyroxine sodium; systemic

1.4

25.6

1542

11806

AA9CW, ,

NOMESCO Finland

9.1

25.6

N06AX16

ATC

venlafaxine; oral

1.5

25.4

952

6704

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

25.3

396

2258

N30.0

ICD-10 Finland

Acute cystitis

1.4

25.2

1092

7902

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

4.8

25.2

117

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

5.6

25.1

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

6.0

25.1

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

25.0

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.5

25.0

Z50.5

ICD-10 Finland

Speech therapy

2.7

25.0

132

490

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

7.4

25.0

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.9

25.0

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

24.9

355

1967

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.6

24.9

235

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

24.8

162

667

N05AX12

ATC

aripiprazole; systemic

2.0

24.8

281

1444

N80

ICPC

Head injury other

2.4

24.8

170

716

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

10.0

24.7

N05AB03

ATC

perphenazine; systemic, rectal

2.1

24.7

248

1221

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

3.1

24.6

104

342

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

4.1

24.5

161

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

24.2

5483

49792

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

24.1

1336

10085

R5110, ,

SPAT

1.7

24.0

440

2625

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.3

23.8

184

817

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.6

23.8

JN4BD

NOMESCO Finland

Extensive body CT

1.5

23.6

710

4778

F10.24

ICD-10 Finland

Alcohol depence active use

2.7

23.5

122

449

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.5

23.5

145

582

N03AA02

ATC

phenobarbital; systemic

19.5

23.4

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

5.4

23.3

F06.0

ICD-10 Finland

Organic hallucinosis

7.0

23.3

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.4

23.2

157

657

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.3

23.2

266

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

1.9

23.2

273

1422

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

3.4

23.2

237

ZX095

NOMESCO Finland

Combined chemoradiotherapy

3.9

23.1

168

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

23.1

2029

16392

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

54.1

23.0

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

22.9

N03AD01

ATC

ethosuximide; oral

+∞

22.9

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

6.9

22.9

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.3

22.8

259

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

22.8

267

1389

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

4.0

22.8

161

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.2

22.7

144

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

4.9

22.7

100

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.8

22.7

371

2144

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

120.3

22.6

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

22.6

2202

18030

S00.0

ICD-10 Finland

Superficial injury of scalp

2.2

22.5

181

817

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

20.7

22.5

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.4

22.5

232

Z00.0

ICD-10 Finland

General medical examination

1.4

22.3

1375

10543

S18

ICPC

Laceration/cut

1.3

22.3

3302

28442

WZC30

NOMESCO Finland

Teaching

1.4

22.3

1078

7946

D21

ICPC

Swallowing problem

2.6

22.1

123

469

N06AB06

ATC

sertraline; oral

1.5

22.1

762

5271

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

4.2

22.0

135

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

62.6

21.8

J01EA01

ATC

trimethoprim; systemic

1.3

21.6

1732

13798

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

7.4

21.6

M01AH05

ATC

etoricoxib; oral

0.8

21.6

3498

39715

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

8.7

21.5

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.4

21.2

221

AAK80

NOMESCO Finland

Partial excision of skull cap

18.9

21.2

F10.20

ICD-10 Finland

Alcohol dependence currently independent

2.4

21.2

145

611

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.2

21.0

252

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

21.0

918

6645

OAB48, ,

SPAT

0.6

20.8

428

6740

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

20.8

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

20.8

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.7

20.8

181

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

17.8

20.8

F06.32

ICD-10 Finland

Organic depression

6.6

20.8

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

24.2

20.8

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

7.7

20.8

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.7

20.7

365

2153

WX704

NOMESCO Finland

Intubation

1.6

20.7

546

3565

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

37.2

20.7

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

20.7

376

2237

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.7

20.7

367

2169

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.9

20.7

333

N05AD03

ATC

melperone; systemic

2.8

20.6

102

367

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

20.6

478

3031

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

20.5

490

3129

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.7

20.4

111

419

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

16.9

20.4

N06DA03

ATC

rivastigmine; oral, transdermal

1.8

20.3

290

1609

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

4.8

20.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

20.3

480

3057

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

20.2

712

4944

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.7

20.2

105

387

F06.7

ICD-10 Finland

Mild cognitive disorder

2.1

20.2

202

994

C02AC05

ATC

moxonidine; oral

1.8

20.1

312

1775

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

8.4

20.1

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.3

20.1

119

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

6.4

20.0

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

20.0

412

2534

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

4.5

20.0

107

N07BB01

ATC

disulfiram; oral

1.8

20.0

285

1581

G44.2

ICD-10 Finland

Tension-type headache

1.4

20.0

887

6435

G93.4

ICD-10 Finland

Encephalopathy, unspecified

5.9

19.9

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.0

19.9

137

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

57.6

19.9

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

19.8

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

19.8

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

19.8

140

599

C10AA01

ATC

simvastatin; oral

1.2

19.7

2873

24606

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

19.6

298

1685

C71

ICD-10 Finland

Malignant neoplasm of brain

200.4

19.6

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

200.4

19.6

U04

ICPC

Incontinence urine

1.7

19.5

350

2075

F07.2

ICD-10 Finland

Postconcussional syndrome

7.7

19.5

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.5

19.5

655

4506

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

40.1

19.5

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.2

19.5

122

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

19.4

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

19.4

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

19.4

146

642

SPAT1263

SPAT

Sampling

1.2

19.4

3053

26359

A07

ICPC

Coma

4.6

19.3

N05AF03

ATC

chlorprothixene; systemic

2.1

19.3

171

804

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

6.3

19.2

N06AX22

ATC

agomelatine; oral

2.2

19.2

161

741

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

7.9

19.1

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.1

19.1

262

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.2

19.0

237

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

19.0

464

2979

N05CD02

ATC

nitrazepam; oral

2.5

18.9

120

489

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

55.1

18.9

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

34.4

18.9

SPAT1172

SPAT

Guidance concerning hydration

2.2

18.9

163

759

SPAT1101

SPAT

Orthostatic test

1.8

18.8

297

1699

R60.0

ICD-10 Finland

Localized oedema

1.4

18.8

815

5884

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.1

18.8

244

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.2

18.8

229

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

18.7

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

18.7

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

70.0

18.7

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.2

18.6

235

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

18.6

905

6665

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

18.6

115

463

RS122, ,

NOMESCO Finland

5.2

18.6

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

20.8

18.6

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

18.5

2804

24074

AA1AA

NOMESCO Finland

Head X-ray examination

3.1

18.5

241

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.2

18.5

156

720

SPAT1210

SPAT

Application of cast or individual aid

1.8

18.4

278

1569

SPAT1153

SPAT

Removal of sutures

1.3

18.4

2155

17967

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

2.6

18.4

103

395

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

18.4

621

4277

J01DB01

ATC

cefalexin; oral

1.3

18.3

6533

61293

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.8

18.3

259

1434

RS340, ,

NOMESCO Finland

5.3

18.2

RL140, ,

NOMESCO Finland

5.9

18.2

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

18.2

612

4212

W06

ICD-10 Finland

Fall involving bed

3.3

18.1

209

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

18.0

199

1016

SPAT1260

SPAT

Consultation of another employee

1.3

18.0

1202

9308

N05BA02

ATC

chlordiazepoxide; systemic

2.1

17.9

161

761

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

32.9

17.9

N05AH02

ATC

clozapine; systemic

2.3

17.9

127

545

P29

ICPC

Psychological sympt/compl other

1.6

17.9

469

3060

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

17.8

149

685

W10

ICD-10 Finland

Fall on and from stairs and steps

1.7

17.7

351

2138

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

18.0

17.7

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

+∞

17.7

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

17.7

34509

ICD-8 Finland

Epilepsy, Absentia epileptica NUD

+∞

17.7

AA11X, ,

NOMESCO Finland

+∞

17.7

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

1.9

17.7

215

1134

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.8

17.7

270

1531

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

6.1

17.6

G43.3

ICD-10 Finland

Complicated migraine

2.5

17.5

113

464

AAA40

NOMESCO Finland

Insertion of intracerebral electrodes

180.3

17.5

RS121, ,

NOMESCO Finland

3.4

17.5

179

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.2

17.4

149

691

C07AA05

ATC

propranolol; systemic

1.3

17.4

1319

10394

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.6

17.4

427

2743

G93.6

ICD-10 Finland

Cerebral oedema

28.8

17.4

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

3.1

17.4

240

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

18.6

17.3

S02.10

ICD-10 Finland

Fracture of base of skull, closed

4.4

17.3

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

42.0

17.3

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

17.2

156

740

WF004

NOMESCO Finland

Palliative radiotherapy

2.2

17.2

148

688

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

17.2

430

2774

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

17.2

781

5683

X58

ICD-10 Finland

Exposure to other specified factors

1.4

17.2

969

7309

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.0

17.2

176

875

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.4

17.2

737

5310

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

17.2

790

10637

N04AA02

ATC

biperiden; systemic

2.3

17.1

126

549

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

17.1

426

2746

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.6

17.1

369

P72

ICPC

Schizophrenia

2.3

17.1

131

581

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

17.0

1747

14316

OAA80, ,

SPAT

0.6

17.0

227

4000

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

7.2

16.9

XX3XW, ,

NOMESCO Finland

3.6

16.9

154

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

25.6

16.9

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.0

16.8

184

938

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.7

16.7

333

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

16.7

304

1812

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

4.2

16.7

106

G40.33

ICD-10 Finland

Juvenile absence epilepsy

+∞

16.7

G40.35

ICD-10 Finland

Juvenile absence epilepsy

+∞

16.7

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

16.7

581

4026

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

16.5

401

2569

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

170.2

16.5

K59.0

ICD-10 Finland

Constipation

1.6

16.4

380

2407

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

23.0

16.4

XX1ZW

NOMESCO Finland

Very extensive written report from radiologist

4.3

16.4

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

16.3

196

1030

R13

ICD-10 Finland

Dysphagia

1.5

16.3

444

2923

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

16.3

354

2210

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

16.3

371

2343

RS230, ,

NOMESCO Finland

3.6

16.3

144

A99

ICPC

Disease/condition unspecnature/site

1.5

16.2

609

4280

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

16.2

441

2901

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.6

16.2

374

N06DX01

ATC

memantine; oral

1.5

16.1

473

3162

5AB01, ,

NOMESCO Finland

6.8

16.1

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

30.1

16.1

I61.6

ICD-10 Finland

Intracerebral haemorrhage, multiple localized

6.0

16.0

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.7

16.0

270

1576

C07AB07

ATC

bisoprolol; oral

1.2

16.0

3388

29981

N75

ICPC

Benign neoplasm nervous system

18.5

16.0

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.8

15.9

285

S72.0

ICD-10 Finland

Fracture of neck of femur

1.7

15.9

262

1519

ZXA05

NOMESCO Finland

Left side

1.3

15.8

1644

13479

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

15.8

392

2525

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.1

15.8

148

713

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.1

15.7

150

727

SPAT1167

SPAT

Insertion of urinary catheter

1.8

15.7

217

1194

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

33.4

15.7

J01CA08

ATC

pivmecillinam; oral

1.2

15.7

2527

21753

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

6.9

15.7

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.6

15.7

386

2483

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.3

15.7

113

489

N27

ICPC

Fear of neurological disease other

2.3

15.7

117

514

E86

ICD-10 Finland

Volume depletion

2.0

15.7

168

850

XX9WW, ,

NOMESCO Finland

+∞

15.6

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

15.6

1595

13048

I69

ICD-10 Finland

Sequelae of cerebrovascular disease

4.6

15.6

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

3.9

15.6

116

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

17.2

15.6

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.7

15.5

263

1537

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

22.0

15.5

A46

ICD-10 Finland

Erysipelas

1.3

15.5

965

7386

C71.91

ICD-10 Finland

Malignant tumor in unspecified location in the brain grade II glioma

160.2

15.5

N02BF02

ATC

pregabalin; oral

1.6

15.5

365

2324

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

13.7

15.5

RT150, ,

NOMESCO Finland

4.0

15.4

108

N06AX03

ATC

mianserin; oral

1.7

15.3

297

1802

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

15.3

443

2956

EBA00

NOMESCO Finland

Extraction of tooth

1.2

15.2

2536

21888

N05BA12

ATC

alprazolam; oral

1.4

15.2

630

4508

G30.8

ICD-10 Finland

Other Alzheimer disease

2.0

15.2

160

804

ZXA00

NOMESCO Finland

Right side

1.3

15.1

1759

14605

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

3.4

15.1

161

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.7

15.1

265

1565

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.5

15.1

142

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.1

15.0

135

641

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

14.9

605

4314

I67.8

ICD-10 Finland

Other specified cerebrovascular diseases

4.5

14.9

G83.9

ICD-10 Finland

Paralytic syndrome, unspecified

5.8

14.9

C71.81

ICD-10 Finland

Overall malignant tumor of the brain grade II glioma

56.7

14.8

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

56.7

14.8

P99

ICPC

Psychological disorders other

1.9

14.7

190

1024

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

14.7

696

5098

RS142, ,

NOMESCO Finland

4.9

14.7

2151

FHL

Resection, big brain

25.0

14.7

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

18.4

14.7

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.1

14.6

128

601

3457B

ICD-9 Finland

Epilepsy, Epilepsia partialis continua[EPILEPSIA PARTIALIS CONTINUA]

+∞

14.6

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

14.6

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.4

14.6

155

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

11.8

14.5

N06AG02

ATC

moclobemide; oral

1.7

14.5

262

1561

C71.93

ICD-10 Finland

Malignant tumor in an unspecified localization in the brain grade IV glioma

36.1

14.4

SPAT1251

SPAT

Organisation of medication

1.7

14.3

234

1354

9070A

ICD-9 Finland

Late effects of injuries to the nervous system, Late effect of intracranial injury without mention of skull fracture

12.5

14.3

SPAT1104

SPAT

Monitoring of emergency patient

1.5

14.3

429

2884

GD1AA, ,

SPAT

0.7

14.3

376

5616

R56

ICD-10 Finland

Convulsions, not elsewhere classified

27.2

14.2

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.2

14.2

119

549

RS211, ,

NOMESCO Finland

3.9

14.2

106

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

3.3

14.2

163

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

14.1

398

2639

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

14.0

1223

9798

R33

ICD-10 Finland

Retention of urine

1.4

14.0

527

3704

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.5

14.0

399

2653

RS313, ,

NOMESCO Finland

4.8

14.0

4373A

ICD-9 Finland

Other and ill-defined cerebrovascular disease, Cerebral aneurysm, nonruptured

10.9

14.0

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.5

14.0

353

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.1

13.9

136

666

XF404

NOMESCO Finland

Ambulatory ECG

1.4

13.9

572

4088

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

10.0

13.9

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.9

13.9

103

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.8

13.9

205

1152

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.2

13.8

108

484

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.3

13.8

100

434

D33.2

ICD-10 Finland

Benign neoplasm: Brain, unspecified

17.5

13.8

D33.0

ICD-10 Finland

Benign neoplasm: Brain, supratentorial

53.4

13.8

9401/3-C71.1

ICD-O-3

Astrocytoma, anaplastic, NOS, of frontal lobe

53.4

13.8

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

13.8

450

3079

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

13.7

383

2535

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

1.7

13.7

222

1284

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

13.6

2634

23011

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

13.6

177

957

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.0

13.6

204

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

1.7

13.5

220

1273

K59.09

ICD-10 Finland

Constipation, unspecified

1.5

13.5

429

2919

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.4

13.5

359

SPAT1310

SPAT

Counselling related to known health issue

1.2

13.4

2170

18637

AAD00

NOMESCO Finland

Evacuation of epidural haematoma

18.2

13.3

AAA20

NOMESCO Finland

Insertion of intraventricular pressure monitoring device

5.6

13.3

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.7

13.3

218

1264

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.8

13.3

198

1117

85100

ICD-8 Finland

Cerebral laceration and contusion, Without mention of open intracranial wound

4.7

13.3

P03

ICPC

Feeling depressed

1.4

13.2

619

4525

SPAT1050

SPAT

Extensive neurological examination

2.0

13.2

143

728

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

2.7

13.2

263

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.5

13.1

126

K08.3

ICD-10 Finland

Retained dental root

1.5

13.1

482

3374

J01DA01

ATC

[U] cefalexin

1.2

13.1

4495

41268

S22.4

ICD-10 Finland

Multiple fractures of ribs

2.0

13.0

137

690

P76

ICPC

Depressive disorder

1.5

13.0

392

2638

CS494

NOMESCO Finland

Other visual field testing

1.9

13.0

157

830

CS444

NOMESCO Finland

Visual field testing with Octopus automated perimetry

1.8

12.9

202

1155

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.5

12.9

318

S70.0

ICD-10 Finland

Contusion of hip

1.7

12.9

252

1533

2132

FHL

Ventricular operators sunt

22.5

12.9

PA2MT

NOMESCO Finland

Endovascular closure of very extensive brain aneurysm

5.6

12.9

S06.8

ICD-10 Finland

Other intracranial injuries

5.6

12.9

N06DA02

ATC

donepezil; oral

1.5

12.8

366

2434

N05AF05

ATC

zuclopenthixol; systemic

2.8

12.8

216

G80.8

ICD-10 Finland

Other cerebral palsy

50.0

12.8

R51

ICD-10 Finland

Headache

1.5

12.8

344

2258

C09AA05

ATC

ramipril; oral

1.2

12.8

1625

13594

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.6

12.8

267

9539/1-C70.0

ICD-O-3

Atypical meningioma of cerebral meninges

14.0

12.7

F06.30

ICD-10 Finland

Organic manic syndrome

14.0

12.7

J96.0

ICD-10 Finland

Acute respiratory failure

2.4

12.7

369

F40.2

ICD-10 Finland

Specific (isolated) phobias

3.0

12.7

185

Z29

ICPC

Social problem NOS

1.9

12.7

144

745

PAF14

NOMESCO Finland

Thrombendarterectomy of internal carotid artery

2.2

12.6

445

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

12.6

318

2058

NFJ52

NOMESCO Finland

Internal fixation of fracture of upper femur with screws and sideplate

3.0

12.6

175

K92.0

ICD-10 Finland

Haematemesis

1.9

12.6

161

866

G03.9

ICD-10 Finland

Meningitis, unspecified

4.4

12.6

4301A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACH.POST MALFORMAT.ARTERIOVENOSAM]

69.9

12.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.5

12.6

342

2252

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.5

12.5

299

2174

FHL

Delete a block

+∞

12.5

9382/3-C71.9

ICD-O-3

Oligoastrocytoma, NOS, of brain, NOS

+∞

12.5

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

12.5

332

2175

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

1.9

12.4

152

806

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.5

12.4

306

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

12.4

423

2918

G40.5

ICD-10 Finland

Special epileptic syndromes

130.1

12.4

23810

ICD-8 Finland

Neoplasm of unspecified nature of eye, brain and other parts of nervous system, Brain

20.0

12.4

ZXE21

NOMESCO Finland

Procedure duration at least 3 but less than 4 hours

3.1

12.4

161

A10AB05

ATC

insulin aspart; parenteral

1.4

12.4

499

3553

G91.8

ICD-10 Finland

Other hydrocephalus

13.1

12.4

AA1AM

NOMESCO Finland

Short MRI examination of brain with 3 Tesla magnet

5.6

12.4

M05BA04

ATC

alendronic acid; oral

1.4

12.4

497

3538

N06AB03

ATC

fluoxetine; oral

1.3

12.4

753

5739

R4120, ,

SPAT

2.7

12.4

243

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.6

12.3

256

1582

Z08

ICPC

Social welfare problem

2.3

12.3

381

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

12.3

2937

26101

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

12.2

809

6239

I61.5

ICD-10 Finland

Intracerebral haemorrhage, intraventricular

5.8

12.2

A01

ICPC

Pain general/multiple sites

1.4

12.2

567

4139

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.5

12.2

285

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.1

12.2

ZX120

NOMESCO Finland

Intravenous

1.4

12.1

597

4400

H50.31

ICD-10 Finland

Intermittent exotropia

2.7

12.1

234

78259

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD

4.9

12.1

AWE00

NOMESCO Finland

Reoperation for deep heamorrhage in surgery of the nervous system

6.0

12.1

N06AX21

ATC

duloxetine; oral

1.3

12.1

706

5346

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

12.1

1194

9706

R06.4

ICD-10 Finland

Hyperventilation

2.2

12.1

101

467

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.5

12.0

410

2829

R2110

NOMESCO Finland

Giving the first information

1.5

12.0

400

2747

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

3.5

12.0

119

C71.43

ICD-10 Finland

Malignant tumor of the occipital lobe grade IV glioma

26.7

12.0

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

12.0

1429

11867

85190

ICD-8 Finland

Cerebral laceration and contusion, Late effect

9.2

11.9

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.7

11.9

392

5611

V03AA01, ,

ATC

2.2

11.9

457

N03AA03

ATC

primidone; oral

4.8

11.9

D33.04

ICD-10 Finland

Temporal lobe

46.7

11.9

P15

ICPC

Chronic alcohol abuse

1.8

11.8

182

1038

S01.41

ICD-10 Finland

Open wound in the temple-jaw region

2.4

11.7

333

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

11.7

488

3496

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.4

11.7

315

N87

ICPC

Parkinsonism

2.2

11.7

447

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

1.8

11.7

165

917

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.7

11.6

203

1199

AAG20

NOMESCO Finland

Stereotactic intracranial implantation of electrodes

4.5

11.6

F01.19

ICD-10 Finland

Multi-infarct dementia without information on additional symptoms

5.5

11.6

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.8

11.6

169

948

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

1.9

11.6

135

705

96698

ICD-8 Finland

Other antiepileptics

65.0

11.6

2250A

ICD-9 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

18.9

11.6

9663A

ICD-9 Finland

Poisoning by anticonvulsants and anti-Parkinsonism drugs, Other and unspecified anticonvulsants[MYRKYTYS:KARBAMATSEPIINI]

18.9

11.6

I63

ICD-10 Finland

Cerebral infarction

2.7

11.6

223

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

1.8

11.5

170

957

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.3

11.5

795

6169

RT490, ,

NOMESCO Finland

11.1

11.5

WF099

NOMESCO Finland

Other radiotherapy

3.1

11.5

153

9505/1-C71.9

ICD-O-3

Ganglioglioma, NOS, of brain, NOS

+∞

11.5

AA5JS

NOMESCO Finland

Extensive PET-MRI of brain metabolism

+∞

11.5

3456B

ICD-9 Finland

Epilepsy, Infantile spasms[EPILEPSIA MYOCLONICA CUM ASTASIA]

+∞

11.5

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

9.2

11.5

AAK85

NOMESCO Finland

Replantation of previously excised part of skull cap

120.1

11.4

R63.1

ICD-10 Finland

Polydipsia

4.4

11.4

6489X

ICD-9 Finland

Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Other current conditions classifiable elsewhere

4.8

11.4

R93.0

ICD-10 Finland

Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

4.8

11.4

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

4.5

11.4

ZX090

NOMESCO Finland

Other technic of radiotherapy

1.8

11.4

160

888

S00.8

ICD-10 Finland

Superficial injury of other parts of head

2.0

11.4

120

606

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.1

11.4

102

485

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

11.4

817

6375

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

11.3

277

1782

22500

ICD-8 Finland

Benign neoplasm of brain and other parts of nervous system, Brain

35.0

11.2

SPAT1276

SPAT

Outlining of treatment with patient or their family members

1.8

11.2

152

834

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.4

11.2

297

N04BA02

ATC

levodopa and decarboxylase inhibitor; oral

1.7

11.2

223

1364

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

8.9

11.2

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.3

11.2

365

S20.2

ICD-10 Finland

Contusion of thorax

1.5

11.2

324

2164

F80.2

ICD-10 Finland

Receptive language disorder

3.3

11.2

120

Z60.8

ICD-10 Finland

Other problems related to social environment

4.0

11.2

R62.0

ICD-10 Finland

Delayed milestone

2.8

11.2

188

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.7

11.1

221

1352

WX402

NOMESCO Finland

General anaesthesia

1.2

11.1

1368

11391

SPAT1307

SPAT

Psychosocial counselling and guidance

1.5

11.1

376

2592

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

2.9

11.1

183

A98

ICPC

Health maint/preventive medicine

0.8

11.1

7606

78151

C70.0

ICD-10 Finland

Malignant neoplasm: Cerebral meninges

20.0

11.1

C07AB02

ATC

metoprolol; systemic

1.2

11.1

1287

10651

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

5269

34115

2.36

322.16

8.3

6.9

1.20

1.21

mmol/l

29.92

4641

29022

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

698

1460

5.11

314.47

1.4

1.5

3.86

3.72

mmol/l

2.25

657

1365

(3027801) Oxygen [Partial pressure] in Arterial blood

1883

7751

2.82

308.39

7.7

7.3

14.17

12.37

kpa

25.74

1809

7366

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1883

7753

2.82

308.22

7.7

7.3

5.03

5.08

kpa

1.86

1809

7367

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

691

113.51

307.65

3.3

2.1

30.14

27.63

umol/l

0.63

537

(3009466) Valproate [Moles/volume] in Serum or Plasma

1360

637

25.07

307.65

3.6

5.7

367.38

364.07

umol/l

0.20

1190

540

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

764

1654

4.96

307.65

1.5

1.6

552.02

506.65

mg/l

1.27

733

1570

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5004

30895

2.44

307.65

7.5

6.3

1.20

1.21

mmol/l

33.35

4744

28217

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

452

581

8.14

307.65

1.7

1.4

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

442

388

11.94

307.65

1.8

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

244

96.46

307.65

3.5

2.2

42.24

38.06

umol/l

0.30

225

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4549

20223

3.59

307.65

3.4

2.1

226.68

218.07

u/l

0.16

4416

18932

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1215

352.23

307.65

2.6

2.2

54.97

37.90

umol/l

2.32

1073

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2484

10696

2.84

307.65

2.3

28.95

29.99

11.07

2414

10366

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

930

2279

4.44

307.65

2.3

2.4

345.53

566.29

ug/l

1.37

887

2145

(3003396) Base excess in Arterial blood by calculation

1877

7735

2.81

306.57

7.7

7.3

1.15

1.01

mmol/l

0.89

1465

6058

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

210

23.35

290.76

2.3

2.0

20.72

14.79

umol/l

4.49

210

(3044290) Cell count panel - Cerebral spinal fluid

642

1349

5.05

287.22

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

662

1455

4.84

280.64

1.6

1.7

25.47

19.62

e6/l

0.36

531

1104

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

661

1455

4.83

279.69

1.7

1827.31

3463.32

e6/l

0.28

555

1165

(3013826) Glucose [Moles/volume] in Serum or Plasma

5759

40908

2.18

251.49

7.2

4.7

6.60

6.71

mmol/l

2.94

5549

38156

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

123

77.92

230.00

1.0

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

333

489

7.04

215.69

1.4

1.2

2.26

2.01

mmol/l

2.27

310

453

(3022217) INR in Platelet poor plasma by Coagulation assay

4651

31856

1.98

206.37

16.2

15.4

1.23

1.28

inr

3.71

1296

9343

(3023183) Ammonium ion [Moles/volume] in Plasma

565

1425

4.17

199.81

2.9

31.71

34.19

umol/l

1.48

506

1297

(3016502) Oxygen saturation in Arterial blood

1537

6955

2.47

199.63

8.6

7.7

96.18

95.64

2.64

1489

6682

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1450

6392

2.52

199.22

8.7

8.0

123.61

121.59

g/l

3.39

1417

6215

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

267

342

8.02

195.02

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

260

333

8.01

189.90

1.2

1.1

—

(3023368) Bacteria identified in Blood by Culture

3076

18798

1.98

184.73

4.5

4.3

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3881

25713

1.91

182.53

4.8

3.6

46.86

78.67

ng/l

0.69

2997

17352

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

243

320

7.78

173.28

1.7

1.4

—

(3016018) Differential panel - Cerebral spinal fluid

354

726

5.04

161.82

1.5

1.7

—

(3018418) pH of Serum or Plasma

3136

19957

1.89

161.78

4.2

4.1

7.40

0.41

591

3830

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2024

11163

2.06

158.25

3.9

3.7

0.81

0.82

mmol/l

0.68

1899

10460

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1096

4705

2.52

156.91

6.7

8.4

24.35

24.78

mmol/l

3.99

1086

4671

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

903

3580

2.70

151.95

7.4

9.7

24.25

24.26

mmol/l

0.04

885

3452

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1013

4275

2.55

150.01

8.2

9.2

1.41

1.36

0.63

1007

4245

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1004

4246

2.54

147.92

10.2

6.7

24.63

24.48

mmol/l

0.64

963

4032

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1972

11175

1.99

140.72

2.0

1.8

—

(3019060) Gas panel - Arterial blood

1018

4460

2.45

138.58

7.3

4.6

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

277

537

5.29

134.90

1.8

1.4

0.74

1.39

promille

8.77

221

413

(3014111) Lactate [Moles/volume] in Serum or Plasma

1254

6125

2.22

132.23

6.3

7.3

1.45

1.35

mmol/l

2.13

1222

5940

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

168

198

8.63

131.25

1.3

1.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4101

29654

1.72

128.58

5.6

5.0

34.95

35.57

g/l

9.09

3855

27520

(3003181) Sodium [Moles/volume] in Urine

407

1113

3.78

127.83

1.5

72.72

64.21

mmol/l

2.86

338

901

(3018405) Lactate [Moles/volume] in Arterial blood

646

2365

2.87

125.86

4.9

3.9

1.53

1.38

mmol/l

1.82

640

2325

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1264

6332

2.16

124.57

2.4

2.2

371.14

371.44

nmol/l

0.02

1164

5828

(3020891) Body temperature

702

2733

2.70

121.51

6.0

4.7

—

(3000991) Gas panel - Venous blood

1223

6199

2.13

116.38

7.0

8.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1415

7663

2.01

112.21

1.9

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1417

7686

2.01

111.84

1.9

1.8

—

(3033658) Prothrombin time (PT) actual/Normal

2677

17763

1.73

110.42

4.5

4.2

89.46

88.95

0.49

2610

17314

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4638

35517

1.65

110.25

8.3

6.2

10.04

11.95

umol/l

20.02

4404

33631

(3023410) Appearance of Cerebral spinal fluid

289

687

4.31

109.91

1.7

2.1

—

(3026008) Bacteria identified in Urine by Culture

3004

20592

1.70

109.80

3.5

3.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1265

6892

1.98

97.51

3.8

4.5

5.89

5.82

kpa

1.73

1230

6677

(3015377) Calcium [Moles/volume] in Serum or Plasma

3185

22697

1.63

97.10

4.3

3.3

2.34

2.35

mmol/l

12.27

2825

19983

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1454

8312

1.90

97.05

10.2

7.0

—

(3024354) Oxygen [Partial pressure] in Venous blood

1100

5733

2.05

95.97

3.5

4.0

4.65

4.66

kpa

0.06

1066

5535

(3002032) Base excess in Venous blood by calculation

1251

6868

1.96

94.05

3.8

4.5

1.94

1.82

mmol/l

0.67

1077

5738

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

842

4043

2.20

90.77

1.6

1.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

135

195

7.01

88.60

1.1

—

(3012544) pH of Venous blood

1262

7121

1.90

86.87

3.8

4.5

7.37

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

154

262

5.96

86.23

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

130

188

7.00

85.23

1.2

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

168

317

5.38

84.26

1.7

1.2

50.06

69.17

1.88

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

130

192

6.85

83.59

1.2

1.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

5540

45841

1.56

83.48

5.5

4.4

2784.31

1833.85

e6/l

0.41

636

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

130

193

6.82

83.18

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

124

176

7.13

82.69

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1068

5927

1.91

76.69

2.7

2.3

5.79

7.36

ug/l

2.69

922

5143

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1510

9329

1.75

76.25

5.4

6.4

1.03

1.06

mmol/l

3.56

1406

8698

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

238

643

3.78

75.89

1.1

1.0

—

(3036489) Thrombin time

594

2655

2.33

75.67

2.1

2.7

21.41

21.71

0.48

540

2320

(3044640) Blood type and Crossmatch panel - Blood

3011

22125

1.55

75.53

2.6

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1928

12772

1.65

74.89

1.8

1.7

1205.86

1165.81

nmol/l

1.20

1524

9643

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

12.50

73.41

1.2

1.0

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1134

6513

1.85

72.94

6.3

7.9

7.86

9.72

mmol/l

18.10

1079

6215

(3051593) INR in Capillary blood by Coagulation assay

151

296

5.17

72.59

4.6

12.6

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

672

3220

2.18

72.27

3.1

3.2

1.32

1.25

0.87

667

3198

(3013650) Neutrophils [#/volume] in Blood by Automated count

4950

40615

1.50

72.21

11.3

9.1

4.05

4.11

e9/l

0.80

4363

35345

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

89.73

72.00

1.1

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

9.96

70.98

1.2

1.1

—

(3006315) Basophils [#/volume] in Blood

4398

35454

1.48

68.45

6.8

6.0

0.04

e9/l

10.34

3827

30587

(3001604) Monocytes [#/volume] in Blood

4386

35366

1.48

67.99

6.8

6.0

0.59

e9/l

0.15

3824

30520

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

138

265

5.27

67.91

1.2

1.1

748.28

417.28

ng/l

0.21

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6136

52973

1.52

67.52

9.6

7.4

80.97

79.52

u/l

1.32

5828

49897

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

635

3064

2.16

66.95

4.3

4.2

50.87

48.59

1.59

627

3022

(3019198) Lymphocytes [#/volume] in Blood

4490

36451

1.47

66.73

6.9

6.1

1.82

1.94

e9/l

2.59

3975

32189

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1821

12209

1.62

66.29

3.2

3.0

2.43

2.45

mmol/l

7.36

1606

10643

(3013115) Eosinophils [#/volume] in Blood

4502

36627

1.47

65.78

7.2

6.3

0.17

0.20

e9/l

16.59

3962

32072

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

9.58

65.61

1.2

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

204

553

3.75

64.74

1.2

1.1

40.56

40.84

mg/l

0.03

175

454

(40760892) CBC W Ordered Manual Differential panel - Blood

4142

33269

1.46

63.96

7.4

6.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

787

4182

1.97

63.72

3.5

3.7

129.85

129.25

g/l

0.32

774

4080

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

198

535

3.76

63.14

1.2

1.1

266.33

261.92

mg/l

0.11

181

467

(3027273) Bicarbonate [Moles/volume] in Venous blood

659

3299

2.08

63.00

3.7

3.6

25.21

25.19

mmol/l

0.05

642

3193

(3008295) Osmolality of Serum or Plasma

228

684

3.39

62.08

1.4

1.5

278.22

280.90

mosm/kgh2o

0.80

167

538

(3026782) Osmolality of Urine

2022

14179

1.55

59.84

3.0

543.53

548.55

mosm/kgh2o

0.45

1760

12187

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2336

16907

1.52

59.75

2.5

2.4

—

(40761535) Cells panel - Urine sediment

967

5615

1.81

59.28

3.8

3.5

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

186

507

3.72

58.57

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

707

3738

1.97

57.90

11.4

9.9

—

(3019150) Specific gravity of Urine by Refractometry

2105

15020

1.53

57.11

5.0

3.9

1.02

kg/l

0.10

286

2294

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

154

6.29

57.08

1.1

—

(4035726) Immunohistochemistry procedure

993

5877

1.78

56.96

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.50

56.78

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

141

6.51

55.96

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

142

6.25

52.03

1.1

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

730

4041

1.88

51.89

1.7

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

819

4705

1.82

51.68

4.2

4.4

1.67

1.66

mmol/l

0.05

609

3446

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

846

4918

1.80

51.31

4.3

4.4

5.20

5.13

kpa

1.62

791

4666

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

159

427

3.77

51.19

1.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

551

2790

2.04

50.82

8.8

4.9

1.70

1.65

0.53

515

2600

(3009343) pH of Capillary blood

834

4858

1.79

50.19

4.3

4.4

7.42

7.41

0.47

104

546

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2799

21584

1.43

49.93

3.1

2.6

58.26

62.86

u/l

0.55

2612

19960

(3007930) Methemoglobin/Hemoglobin.total in Blood

546

2774

2.03

49.88

8.9

5.0

0.93

0.89

1.05

510

2591

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

222

751

3.01

49.52

1.5

1.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3976

32720

1.39

48.30

2.9

2.6

—

(1761868) Lipid panel - Serum or Plasma

1809

24508

0.67

48.04

2.9

2.8

—

(3029937) Albumin [Presence] in Urine by Test strip

2410

18333

1.43

45.38

5.0

4.0

0.00

estimate

2.60

715

6192

(3010421) pH of Blood

397

1852

2.20

45.32

4.4

7.41

7.42

2.39

340

1681

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

203

4.82

43.32

1.4

1.2

23.60

28.08

0.20

(3016038) Potassium [Moles/volume] in Urine

152

447

3.44

42.78

1.5

1.4

33.36

35.69

mmol/l

0.58

133

391

(3019550) Sodium [Moles/volume] in Serum or Plasma

7666

71412

1.58

42.46

26.4

16.1

138.42

139.67

mmol/l

187.88

7555

69551

(3021960) Folate [Moles/volume] in Serum or Plasma

2088

15633

1.44

42.35

1.6

1.5

18.27

20.14

nmol/l

7.52

1856

13433

(3028271) Lactate [Moles/volume] in Capillary blood

271

1110

2.49

41.75

2.3

1.9

2.31

1.70

mmol/l

8.08

265

1088

(3011397) Hemoglobin [Presence] in Urine by Test strip

2142

16159

1.43

41.55

4.4

3.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2863

22729

1.38

41.21

4.2

3.3

32.51

34.75

u/l

0.67

2707

21536

(3030467) Casts [#/volume] in Urine by Automated count

2520

19616

1.40

40.71

3.4

3.2

0.42

0.41

e6/l

0.04

2022

14928

(40758558) Short blood count panel - Blood

2327

17869

1.41

40.68

8.2

7.1

—

(3022096) Basophils/100 leukocytes in Blood

3857

32210

1.35

39.85

7.1

6.3

0.63

0.67

4.50

3637

30054

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

11.81

39.37

1.0

1.1

—

(3039000) Anion gap in Blood

331

1519

2.22

39.33

12.3

6.6

10.98

11.32

mmol/l

1.03

299

1353

(3018572) Chloride [Moles/volume] in Blood

331

1520

2.22

39.27

12.3

6.6

104.75

105.09

mmol/l

0.45

299

1354

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

150

469

3.24

38.32

1.2

1.1

—

(3012501) Base excess in Blood by calculation

340

1595

2.18

38.26

4.5

2.35

2.51

mmol/l

0.59

238

1063

(3019069) Monocytes/100 leukocytes in Blood

3972

33451

1.34

38.21

7.5

6.6

8.95

8.60

9.09

3746

31318

(3013290) Carbon dioxide [Partial pressure] in Blood

340

1596

2.17

38.20

4.6

4.5

5.08

5.00

kpa

1.33

331

1562

(3006504) Eosinophils/100 leukocytes in Blood

3951

33251

1.34

38.17

7.1

6.3

2.61

2.89

11.44

3725

31078

(3036180) Methadone [Presence] in Urine

128

363

3.56

38.12

1.6

3.1

—

(3027315) Oxygen [Partial pressure] in Blood

341

1605

2.17

38.05

4.6

4.5

8.71

8.66

kpa

0.22

332

1570

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

655

3851

1.76

37.83

3.5

5.0

24.06

24.00

mmol/l

0.24

643

3775

(3002582) Erythrocytes [#/volume] in Urine

2689

21394

1.37

37.29

3.6

3.3

63.75

97.16

e6/l

1.28

2161

16447

(36304419) Bacteria [Presence] in Urine

2437

19106

1.38

36.96

3.4

3.2

—

(3000850) Epithelial cells [#/volume] in Urine

1972

14923

1.41

36.87

2.8

2.7

5.86

5.33

e6/l

0.88

1817

13359

(3018095) Leukocytes [#/volume] in Urine

3063

24907

1.35

36.79

4.1

3.8

96.69

94.21

e6/l

0.04

2312

17646

(3023103) Potassium [Moles/volume] in Serum or Plasma

7645

71628

1.52

36.27

25.7

16.2

3.97

mmol/l

0.18

7518

69623

(1616796) Gas panel - Central venous blood

338

1622

2.13

35.89

3.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

184

674

2.77

35.56

1.5

1.8

—

(3015736) pH of Urine

3345

27683

1.34

35.28

4.1

3.3

6.15

5.88

3.26

146

2140

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

5272

46562

1.33

35.21

4.4

3.1

64.98

47.06

u/l

24.02

5006

43405

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

6.54

34.79

1.6

1.1

50.41

59.33

0.52

(40767503) Oxygen content in Capillary blood by calculation

317

1502

2.15

34.78

2.8

2.5

17.00

16.37

1.74

159

789

(3037467) Urinalysis macro (dipstick) panel - Urine

5426

48179

1.33

34.58

5.1

4.2

—

(3019225) pH of Specimen

986

6597

1.56

34.10

4.6

4.3

—

(3002030) Lymphocytes/100 leukocytes in Blood

4040

34458

1.32

34.08

7.2

6.3

26.78

28.15

11.27

3821

32341

(3035350) Ketones [Presence] in Urine by Test strip

4012

34197

1.32

33.95

4.5

3.6

0.00

estimate

3.26

790

6823

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

478

2650

1.85

33.52

2.0

1.8

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

445

2415

1.89

33.37

3.5

3.8

0.37

0.34

u/ml

1.10

301

1382

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1233

8690

1.49

33.33

2.1

1.7

1.72

1.45

16.81

1098

7629

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

387

2013

1.96

32.95

1.3

—

(3018010) Neutrophils/100 leukocytes in Blood

3973

33930

1.31

32.68

7.0

6.1

57.79

56.96

3.89

3763

31821

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1766

13348

1.40

32.68

4.3

3.7

244.17

528.91

ng/l

2.74

1390

10330

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

120

364

3.33

32.26

1.1

1.05

1.08

u/l

0.21

171

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

408

2183

1.91

31.95

2.6

3.3

3.43

3.51

g/l

0.53

388

2080

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.45

31.88

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

486

2750

1.81

31.88

2.5

1.9

2.99

2.36

ug/l

0.38

407

2417

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

129

412

3.16

31.88

1.0

283.54

316.05

ng/l

0.74

280

(3047181) Lactate [Moles/volume] in Blood

407

2197

1.89

31.02

11.2

5.6

1.40

1.31

mmol/l

0.72

359

1930

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

128

416

3.11

30.73

1.0

37.18

43.51

ng/l

1.17

280

(3009261) Glucose [Presence] in Urine by Test strip

4013

34522

1.30

30.44

4.5

3.6

0.00

estimate

2.20

724

6275

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

127

414

3.10

30.34

1.0

732.47

743.85

ng/l

0.09

274

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

771

5004

1.59

30.27

1.8

1.7

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

11.07

30.18

1.2

1.3

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1130

7974

1.48

30.13

4.2

4.3

252.65

242.60

u/l

0.78

1064

7536

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2254

17973

1.34

29.31

2.2

2.3

2.98

2.93

mg/l

0.37

1897

15423

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3296

27719

1.30

29.29

2.1

2.0

94.25

95.13

pmol/l

0.50

1829

14672

(3021601) Nitrite [Presence] in Urine by Test strip

3961

34155

1.29

28.95

5.8

4.8

0.00

estimate

0.80

742

6463

(3028626) Oxygen [Partial pressure] in Capillary blood

394

2161

1.86

28.57

4.6

4.9

8.82

8.61

kpa

1.15

382

2103

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

7496

70603

1.42

28.32

22.1

14.1

23.88

24.12

mg/l

0.26

6521

55729

(3028707) Methadone [Presence] in Urine by Screen method

272

1319

2.10

28.14

2.2

3.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1574

11992

1.38

27.14

2.9

2.8

1.24

1.11

e6/l

0.64

939

6887

(3015235) Bicarbonate [Moles/volume] in Capillary blood

343

1829

1.91

27.14

3.1

3.5

24.28

24.71

mmol/l

1.31

336

1789

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3131

26355

1.29

26.99

4.8

3.7

—

(3022806) Fractional oxyhemoglobin in Capillary blood

204

897

2.30

26.92

2.2

1.9

89.36

89.72

0.43

199

887

(3007853) Bacteria identified in Skin by Aerobe culture

1157

8433

1.43

25.72

1.9

1.8

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1910

15181

1.33

24.68

1.9

1.23

1.24

mg/l

0.07

1484

11515

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

522

3235

1.65

24.64

4.9

4.8

24.86

24.67

mmol/l

0.76

485

3001

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

368

6271

0.57

24.64

1.7

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

5.12

24.20

1.1

1.0

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

201

921

2.21

24.08

5.6

6.9

10.56

11.59

mg/l

2.55

176

843

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

100

4.92

22.67

1.1

1.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.90

22.54

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

363

2088

1.77

22.53

2.6

3.1

186.25

187.78

0.12

345

1990

(21494755) Public health laboratory ask at order entry panel

430

6877

0.61

22.40

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

8.31

22.22

1.8

1.2

25.71

35.52

0.47

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1819

14547

1.32

22.15

1.7

34310353.49

28795934.83

pmol/l

0.15

1536

12113

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

469

2913

1.64

21.94

2.1

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

115

4.54

21.87

1.1

—

(3042936) Bacteria identified in Isolate by Culture

1293

9850

1.37

21.85

2.2

2.0

—

(3022313) Gas panel - Capillary blood

560

3635

1.58

21.83

4.6

4.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

18.88

21.21

1.1

1.0

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2321

19285

1.28

20.88

3.1

3.2

1462.36

1520.42

ng/l

0.23

2023

16506

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5764

53067

1.25

20.59

4.3

3.9

14.35

14.77

pmol/l

28.78

5297

48266

(3014271) Vancomycin [Susceptibility]

335

2.89

20.48

3.1

2.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

300

2.99

20.21

1.9

2.3

151.51

151.88

umol/l

0.00

164

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

228

4211

0.53

20.11

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.29

19.23

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

262

3.07

19.12

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1072

8090

1.37

19.04

2.9

2.7

1.81

1.74

1.60

947

7168

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

147

656

2.26

18.87

2.6

3.0

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

379

2321

1.66

18.75

2.4

3.3

95.03

91.53

2.03

365

2237

(3021901) Oxygen saturation in Capillary blood

245

1324

1.87

18.70

2.8

3.0

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

322

2.81

18.39

2.7

2.4

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6371

67409

0.80

18.34

4.3

4.2

1.46

1.44

mmol/l

3.94

5895

62361

(3005719) IgG [Mass/volume] in Serum or Plasma

753

5384

1.44

18.32

2.5

2.7

10.26

10.46

g/l

0.49

683

4930

(3028679) Herpes simplex virus Ab [Presence] in Serum

369

2.67

18.17

1.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1417

11231

1.31

17.99

3.2

3.0

3.48

2.34

e6/l

3.15

795

6163

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6559

69128

0.80

17.89

4.9

4.7

2.67

2.74

mmol/l

8.58

6072

63929

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

5.83

17.86

1.2

1.1

11.83

21.20

—

(3020630) Protein [Mass/volume] in Serum or Plasma

777

5614

1.42

17.83

2.3

2.5

66.19

66.36

g/l

0.24

698

5095

(4034850) Laboratory test

358

2189

1.66

17.83

12.3

9.9

—

(40757494) Bilirubin.total [Moles/volume] in Blood

379

2.63

17.77

2.3

2.5

42.24

46.53

umol/l

0.07

(3023520) Reticulocytes [#/volume] in Blood

823

6015

1.41

17.69

2.7

2.6

70.67

69.21

e9/l

0.52

619

4508

(3021589) Normoblasts [#/volume] in Blood

3550

31359

1.22

17.60

11.5

9.7

0.00

e9/l

0.45

2904

25521

(3052851) Hemolysis interference index of Serum or Plasma

342

2097

1.66

16.86

3.5

3.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

879

6568

1.38

16.51

2.5

2.4

0.21

g/l

0.19

820

6106

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6451

67912

0.81

15.93

4.4

4.3

4.58

4.62

mmol/l

2.34

6002

63164

(3040151) Glucose [Moles/volume] in Capillary blood

163

812

2.03

15.86

10.1

7.2

7.38

7.31

mmol/l

0.08

141

677

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

606

4278

1.45

15.76

1.3

38.37

56.25

au/ml

1.85

231

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

4.38

15.38

1.8

1.9

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

650

4675

1.42

15.26

2.4

29.82

22.49

au/ml

0.66

367

(3035637) Corticotropin [Mass/volume] in Plasma

181

957

1.91

14.86

1.5

1.6

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

189

1015

1.88

14.79

1.2

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

752

5607

1.37

14.26

4.3

4.0

1.22

1.23

mmol/l

6.03

704

4889

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

258

1538

1.70

14.21

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

258

1538

1.70

14.21

1.4

1.3

—

(3017569) Oxygen content in Arterial blood

319

2.55

13.83

1.6

2.3

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

350

2271

1.56

13.71

2.6

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

320

2045

1.59

13.40

1.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

223

1323

1.70

12.55

1.6

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

154

819

1.90

12.49

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

154

819

1.90

12.49

1.5

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

207

1205

1.73

12.48

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3154

28195

1.18

12.32

2.3

73.72

76.44

nmol/l

6.15

2811

25455

(3013512) EKG study

2236

19390

1.20

12.27

4.5

3.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

617

4565

1.38

12.26

2.1

2.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

186

1056

1.78

12.24

1.3

3.13

4.30

u/ml

1.28

466

(3006184) Hemoglobin [Mass/volume] in Capillary blood

261

1628

1.62

12.12

2.3

2.2

133.61

129.72

g/l

1.94

216

1175

(3008757) Leukocyte morphology finding [Identifier] in Blood

144

761

1.91

11.93

3.4

4.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

325

2.41

11.88

1.7

2.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

355

2396

1.50

11.65

2.1

2.4

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

3.73

11.52

1.0

2.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

197

1158

1.72

11.50

1.6

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

197

1158

1.72

11.50

1.6

1.7

—

(3011412) CD3 cells [#/volume] in Blood

140

743

1.90

11.47

2.4

2.6

1.12

1.20

e9/l

0.39

125

647

(40761511) CBC panel - Blood by Automated count

7575

73193

1.25

11.40

20.6

13.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6212

65091

0.84

11.38

4.0

3.8

1.30

1.29

mmol/l

0.09

5730

59765

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

261

1658

1.59

11.27

1.7

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

321

2.38

11.26

1.1

—

(3024928) Oxygen saturation in Venous blood

240

1497

1.62

11.18

2.9

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

890

7052

1.29

11.02

4.2

3.4

—

(3011985) Renin [Units/volume] in Plasma

160

899

1.79

10.95

1.5

66.42

68.23

mu/l

0.04

146

792

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

263

1695

1.57

10.69

1.7

—

(3016879) Cocaine [Presence] in Urine

406

2863

1.44

10.67

2.0

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

442

3184

1.41

10.32

1.7

1.47

1.52

g/l

0.52

359

2739

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.10

10.12

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

181

1081

1.69

10.03

1.3

4.76

3.82

u/ml

0.26

349

(3013707) Erythrocyte sedimentation rate by Westergren method

5454

51388

1.16

9.99

4.2

4.0

12.41

11.87

mm/h

1.74

5099

47558

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

316

2.29

9.83

1.2

1.1

1700.68

1520.44

miu/ml

0.62

316

(3000764) Benzodiazepines [Presence] in Urine

425

3070

1.40

9.78

2.0

2.2

—

(3028433) Virus identified in Specimen by Culture

256

2.43

9.71

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

116

3.20

9.68

1.1

—

(3028300) Cannabinoids [Presence] in Urine

427

3093

1.40

9.67

2.0

2.2

—

(3027008) Opiates [Presence] in Urine

426

3088

1.40

9.61

2.0

2.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

229

3479

0.65

9.45

1.7

1.6

—

(3011288) Drugs identified in Urine by Screen method

301

2055

1.48

9.40

2.9

3.3

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.81

9.20

1.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

188

1161

1.63

9.20

3.0

3.6

1.66

1.51

0.18

170

1022

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

243

1594

1.54

9.19

1.5

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1323

11207

1.21

8.96

2.5

2.6

12.90

13.09

umol/l

0.40

1211

10443

(3044889) 12 lead EKG panel

5067

47668

1.15

8.93

4.1

3.7

—

(3017181) Myelocytes/100 leukocytes in Blood

741

5899

1.28

8.82

4.4

4.3

1.17

0.94

1.71

332

2005

(40757373) Influenza virus identified in Isolate

140

2.86

8.71

1.5

—

(3027944) Amphetamines [Presence] in Urine

413

3032

1.38

8.67

2.0

2.1

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

194

1226

1.59

8.66

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

281

1926

1.47

8.64

1.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

103

545

1.90

8.63

2.4

2.8

499.66

501.58

e6/l

0.01

444

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

130

2.93

8.62

1.3

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

100

527

1.91

8.49

2.4

2.8

0.22

0.21

e9/l

0.18

440

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1159

13681

0.82

8.44

2.7

3.0

0.75

0.77

ug/l

0.21

811

9051

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

230

1523

1.52

8.37

1.3

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

238

2.36

8.29

1.5

13.26

15.44

pmol/l

1.57

199

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

106

575

1.85

8.25

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

106

575

1.85

8.25

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

106

575

1.85

8.25

1.5

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6642

63847

1.16

8.24

5.2

4.6

2.02

2.12

mu/l

0.21

6179

58561

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

143

852

1.69

8.09

1.2

1.4

979.57

318.67

pmol/l

0.48

127

727

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

160

989

1.63

7.86

1.7

1.6

—

(3000093) Morphology [Interpretation] in Blood Narrative

116

659

1.77

7.79

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

691

5543

1.27

7.74

3.3

2.6

70.73

66.56

ml/min/173m2

1.55

286

2203

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

302

2151

1.42

7.61

2.1

1.7

1.17

1.18

g/l

0.17

291

2038

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

293

2081

1.42

7.51

2.1

1.7

0.22

0.23

g/l

1.11

283

1969

(3037121) Protein [Mass/volume] in Urine

340

2483

1.38

7.42

3.4

3.5

0.27

0.34

g/l

1.40

180

1155

(1175426) CD3 cells/100 lymphocytes in Blood

108

610

1.78

7.42

2.3

2.4

74.23

70.97

1.42

103

583

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

153

950

1.62

7.41

1.4

23.17

25.04

u/l

0.34

129

792

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1213

10368

1.20

7.39

2.5

2.6

2.29

2.34

g/l

2.10

1117

9592

(3002179) Metamyelocytes/100 leukocytes in Blood

671

5395

1.26

7.37

4.1

0.86

0.67

1.45

289

1753

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.22

7.22

1.8

4.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

123

727

1.70

7.21

2.4

2.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

473

3648

1.31

7.20

3.0

2.8

0.39

0.28

e6/l

0.55

462

3563

(3051651) Icteric interference index of Serum or Plasma

436

1.91

7.18

2.5

3.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

146

905

1.62

7.14

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1137

9698

1.20

7.08

2.5

2.6

22.77

22.67

0.07

944

8290

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

102

575

1.78

7.07

2.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

12.01

7.07

1.2

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

134

2.69

7.06

1.9

1.3

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

225

3219

0.69

6.92

1.4

1.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

8.24

6.81

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

158

1013

1.57

6.74

1.2

1.1

118.51

114.87

0.69

140

909

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

405

1.91

6.67

2.9

2.6

44.25

40.03

1.22

221

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

256

2.15

6.65

2.9

2.4

142.37

147.23

nmol/l

0.15

216

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

215

1477

1.47

6.63

5.5

6.2

337.82

2355.03

iu/ml

1.01

217

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

162

1052

1.55

6.54

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

136

848

1.61

6.53

3.3

2.3

104.78

105.53

mmol/l

0.95

136

838

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

597

7358

0.80

6.53

1.4

1.5

—

(3017509) Phencyclidine [Presence] in Urine

3.34

6.53

1.5

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

133

825

1.62

6.52

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

136

850

1.61

6.47

3.3

2.3

4.06

4.08

mmol/l

0.14

136

840

(3033705) Calcium.ionized [Moles/volume] in Venous blood

133

829

1.61

6.41

3.4

2.4

—

(3021440) Promyelocytes/100 leukocytes in Blood

685

5613

1.24

6.39

4.6

4.3

0.17

0.11

1.05

281

1728

(3017354) Segmented neutrophils/100 leukocytes in Blood

117

707

1.66

6.37

2.6

3.6

58.86

56.06

0.74

100

597

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1569

17666

0.86

6.33

1.6

1.34

1.38

mmol/l

0.90

1360

14912

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

520

4136

1.27

6.28

2.9

3.3

4.28

4.51

pmol/l

5.15

470

3664

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

7627

74486

1.18

6.21

14.3

10.1

27.25

26.68

u/l

0.45

7456

71791

(3014148) Varicella zoster virus Ab [Titer] in Serum

145

931

1.57

6.18

1.2

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

326

1.97

6.12

1.6

1.9

159.41

142.74

0.92

310

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

348

2633

1.33

6.11

2.5

2.3

5893.15

5529.62

u/l

0.07

105

1040

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

12.51

6.07

1.1

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

117

718

1.64

6.03

2.7

2.9

20.93

20.11

nmol/l

0.35

106

690

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

170

1142

1.50

5.91

3.0

3.9

391.91

1698.09

u/ml

1.20

(40768804) Tissue Pathology biopsy report

2978

27548

1.12

5.90

2.2

2.1

—

(3023419) Bacteria identified in Sputum by Culture

148

967

1.54

5.86

2.4

2.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

387

2993

1.31

5.84

1.5

1.6

30.97

14.44

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

446

1.80

5.83

1.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

195

1352

1.45

5.79

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

950

1.53

5.69

1.6

1.5

—

(3019977) pH of Arterial blood

378

1.86

5.66

2.3

2.7

7.41

7.43

0.50

134

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

141

924

1.53

5.54

1.3

0.19

0.27

nmol/l

0.57

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

436

1.77

5.36

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

142

2.40

5.35

1.1

1.2

63.57

77.49

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

273

1.98

5.33

2.7

2.5

—

(3025159) Blasts/100 leukocytes in Blood

644

5347

1.22

5.33

4.6

4.3

0.26

0.39

0.24

237

1476

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

625

5178

1.22

5.28

3.7

4.2

80.67

90.41

ng/l

2.35

533

4504

(3039443) Prostate specific Ag panel - Serum or Plasma

1332

0.59

5.28

1.5

1.6

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

143

2.38

5.28

1.1

1.2

74.67

70.62

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.83

5.23

1.3

1.4

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

118

755

1.57

5.18

1.2

1.1

91.64

95.75

1.00

107

708

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.84

5.10

2.3

5.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

393

1.79

5.04

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

497

1.70

5.04

1.1

1.2

—

(3000494) Fungus identified in Specimen by Culture

932

8050

1.18

5.00

1.5

—

(3037756) Immunofixation for Serum or Plasma

196

1402

1.41

4.97

1.4

1.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

123

1845

0.66

4.95

1.4

1.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.86

4.91

2.5

2.1

—

(3051611) Lipemic interference index of Serum or Plasma

112

718

1.57

4.90

2.8

3.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

220

2.05

4.89

1.1

79.62

88.10

0.54

114

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

308

2372

1.31

4.86

1.6

473.85

309.70

titre

0.26

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

201

2.09

4.83

2.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

201

2.09

4.83

2.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

112

1702

0.65

4.82

1.3

1.4

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

182

2522

0.72

4.77

1.6

1.7

5.17

3.94

mg/l

0.53

138

1812

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.57

4.75

1.1

1.57

5.20

u/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

112

1696

0.66

4.74

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

112

1696

0.66

4.74

1.3

1.4

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

350

1.81

4.72

2.2

1.7

1.27

3.27

u/field

2.01

248

(3050129) First trimester maternal screen panel - Serum or Plasma

149

2132

0.69

4.71

1.6

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

113

1700

0.66

4.64

1.3

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

325

2538

1.29

4.63

1.8

1.6

350.45

295.98

mu/l

1.80

297

2298

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

757

6477

1.18

4.56

2.5

2.4

44.89

44.33

u/l

0.02

649

5534

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

254

1.93

4.56

1.6

1.9

180.59

169.38

0.34

239

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

262

1993

1.32

4.54

1.4

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

193

2.08

4.53

1.1

1.3

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

215

2.00

4.44

1.1

1.2

71.08

86.66

1.04

114

(3000492) Spirometry study

579

6868

0.83

4.39

1.5

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

210

2.00

4.34

2.4

3.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

497

1.63

4.30

1.4

1.5

12.68

12.80

u/l

0.06

477

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

152

1074

1.42

4.20

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

268

2073

1.30

4.15

2.7

3.4

30.67

53.20

mg/l

2.47

230

1684

(3002079) Sodium [Moles/time] in 24 hour Urine

299

1.81

4.14

1.2

1.3

158.28

165.58

mmol/24h

0.20

299

(3009214) Lutropin [Units/volume] in Serum or Plasma

287

2242

1.29

4.12

1.5

10.52

8.97

u/l

1.00

234

1765

(3034860) Kappa light chains.free [Mass/volume] in Serum

268

2075

1.30

4.12

2.7

3.4

47.90

86.26

mg/l

0.75

229

1683

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1381

0.65

4.12

1.4

—

(40768800) Prostate Pathology biopsy report

1453

0.66

4.11

1.1

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

111

741

1.50

4.11

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

322

1.77

4.10

3.4

3.5

—

(3049233) Organic acids panel - Urine

4.62

4.05

1.4

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

104

2.41

4.04

1.0

1.4

44.76

74.20

ng/l

0.53

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

10.00

4.00

1.0

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

915

8033

1.15

4.00

3.3

3.0

6.63

8.15

umol/l

3.11

774

6967

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

332

1.75

4.00

2.4

2.6

26.83

28.05

0.32

317

(3006245) CD3-CD19+ cells/100 cells in Blood

347

1.73

3.99

2.4

2.9

11.24

12.23

0.16

327

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.53

3.95

2.4

2.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

952

10759

0.87

3.94

1.3

1.2

19.39

11.27

u/ml

0.63

380

4167

(3028026) IgM [Mass/volume] in Serum or Plasma

503

4209

1.21

3.91

1.8

1.9

1.20

1.32

g/l

1.13

453

3852

(3005033) Fetal Nuchal fold Thickness US

1374

0.66

3.88

1.4

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

253

1962

1.30

3.87

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

277

1.81

3.85

2.0

2.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

255

1982

1.29

3.84

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

132

926

1.43

3.83

1.4

1.5

34.45

32.10

g/l

1.31

127

838

(42529406) Shigella sp [Presence] in Stool by Culture

256

1993

1.29

3.81

1.3

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1415

0.67

3.79

1.4

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

259

2025

1.29

3.74

2.7

3.3

19.04

2.38

ratio

0.45

160

(3015171) Extractable nuclear Ab [Units/volume] in Serum

326

2627

1.25

3.67

1.2

0.53

0.96

u/ml

0.81

241

(3008898) HLA-B27 [Presence]

182

2411

0.75

3.65

1.0

1.1

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

335

1.71

3.62

1.1

1.2

26.14

17.78

u/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

225

1.87

3.61

2.2

2.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

655

7554

0.86

3.59

1.7

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

360

1.67

3.54

1.1

1.2

344.73

340.39

u/l

0.01

330

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

327

1.69

3.37

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

327

1.69

3.37

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

241

1900

1.28

3.30

1.4

1.5

15.43

13.27

iu/ml

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1159

0.66

3.29

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

150

1108

1.36

3.27

1.2

1.4

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

117

831

1.41

3.23

1.7

1.6

—

(3011648) Oxygen content in Venous blood

592

1.49

3.23

3.0

4.2

11.18

11.16

0.01

592

(3028308) Erythrocytes [#/volume] in Pleural fluid

106

740

1.44

3.22

1.4

1.5

91294.77

61051.35

e6/l

0.43

437

(3023199) Leukocytes [#/volume] in Pleural fluid

116

824

1.41

3.21

1.4

1.5

2156.42

2231.57

e6/l

0.07

599

(3026250) Tacrolimus [Mass/volume] in Blood

340

1.65

3.19

32.5

37.4

7.02

7.30

ug/l

0.43

316

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.53

3.19

1.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

164

1.95

3.17

1.1

1.2

309.27

268.53

pmol/l

0.31

115

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

112

1556

0.72

3.12

1.6

—

(3028717) Thiamine [Mass/volume] in Blood

2.47

3.12

1.1

1.2

—

(3003694) ABO and Rh group [Type] in Blood

2130

19899

1.09

3.11

1.4

1.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

258

2068

1.25

3.10

1.9

1.8

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

398

1.59

3.08

10.9

11.9

0.60

0.61

mmol/l

0.15

367

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.83

3.02

1.0

1.1

3.04

1.11

mg/l

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

488

1.52

3.01

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

4.29

2.99

1.1

4.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

4.29

2.99

1.4

474.90

496.35

nmol/l

—

(4200892) Spirometry reversibility

553

4786

1.17

2.98

1.5

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

442

1.54

2.95

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

121

880

1.38

2.95

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

264

1.71

2.94

3.1

2.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

123

898

1.37

2.93

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

227

1.76

2.93

1.4

143.82

190.64

nmol/24h

0.28

227

(3010838) Calcium [Moles/time] in 24 hour Urine

149

1123

1.33

2.89

1.5

1.9

4.66

4.95

mmol/24h

0.58

133

982

(4094501) Cardiovascular stress test using bicycle ergometer

135

1798

0.75

2.89

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.69

2.88

1.2

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

120

876

1.37

2.87

1.4

1.5

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

6.67

2.86

1.0

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

494

1.50

2.86

1.2

1.3

11.38

12.73

u/l

0.45

455

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

129

2.02

2.84

1.2

0.97

135.78

mg/l

1.44

100

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3223

30723

1.08

2.82

3.0

2.9

143.96

126.07

ug/l

1.97

2967

28483

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1041

11446

0.90

2.77

1.3

30.52

31.45

iu/ml

0.07

293

3542

(3001964) Herpes simplex virus Ag [Presence] in Specimen

209

1.77

2.77

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

120

882

1.36

2.76

1.4

1.5

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

8.33

2.75

1.2

1.3

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

8.33

2.75

1.2

1.3

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

293

2418

1.22

2.73

2.2

2.3

2.95

2.96

g/l

0.08

248

2169

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

339

2841

1.20

2.70

1.8

1.9

39.52

39.16

u/l

0.10

307

2521

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

149

1136

1.32

2.70

1.1

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

101

726

1.40

2.67

1.2

—

36.13

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

119

879

1.36

2.67

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.18

2.66

1.2

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

190

1.79

2.65

1.3

16.61

293.75

ug/l

1.22

(3005988) Vibrio sp identified in Specimen by Organism specific culture

119

882

1.35

2.62

1.4

—

(3045788) Cell count panel - Pleural fluid

637

1.42

2.61

1.4

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

167

1300

1.29

2.61

1.5

1.3

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

311

2596

1.20

2.60

2.1

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

311

2598

1.20

2.58

2.1

2.3

7.19

7.42

g/l

1.66

266

2345

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.30

2.57

3.5

2.4

0.65

0.55

u/field

0.14

(3042517) Benzodiazepines panel - Urine

2.22

2.53

4.6

2.8

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

150

1.87

2.50

3.1

2.7

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

143

1.89

2.49

2.8

2.3

1.61

1.57

mmol/l

0.02

103

(3014599) Egg white IgE Ab [Units/volume] in Serum

497

0.56

2.47

1.2

2.42

7.87

u/ml

—

174

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6150

62779

0.93

2.47

5.7

5.6

39.22

39.69

mmol/mol

3.29

5701

58228

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

180

1.78

2.46

1.5

1.4

126.12

131.95

nmol/l

0.07

132

(3020874) Milk IgE Ab [Units/volume] in Serum

496

0.56

2.45

1.1

1.2

0.90

2.69

u/ml

—

205

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

309

2594

1.20

2.45

2.1

2.3

3.58

3.69

g/l

0.65

265

2345

(3000060) B lymphocytes [#/volume] in Blood

271

1.63

2.45

2.3

2.9

1062.38

254.22

e6/l

0.42

154

(40760888) Immunoglobulin light chains.free panel - Serum

197

1579

1.25

2.45

2.9

3.5

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

245

2014

1.22

2.42

1.4

1.3

—

(3004451) EKG impression Narrative

336

1.55

2.38

1.3

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

726

1.37

2.37

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

264

2192

1.21

2.36

2.1

2.3

0.78

0.90

g/l

0.20

213

1877

(3007566) Smooth muscle Ab [Titer] in Serum

236

1938

1.22

2.36

1.3

139.50

152.67

titre

0.07

161

(3033086) Enterovirus NOS Ab [Titer] in Serum

3.64

2.36

1.1

1.0

—

(3017732) Neutrophils [#/volume] in Blood

548

4833

1.14

2.34

3.7

2.8

4.59

4.97

e9/l

0.49

429

3922

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.25

2.33

3.8

3.6

10.43

3.87

—

(3002256) Pathology report gross observation

804

8873

0.90

2.31

1.2

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.31

1.6

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

134

1033

1.30

2.30

1.3

—

(3045424) Erythrocytes [Presence] in Urine

145

1130

1.29

2.29

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

545

1.42

2.28

2.3

2.0

2.51

1.70

u/field

0.54

214

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

658

5885

1.13

2.27

3.0

178.14

213.31

ng/l

1.82

597

5328

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1792

19038

0.93

2.25

4.1

4.2

21.52

22.00

0.65

880

9203

(3012441) Differential panel - Pleural fluid

724

1.36

2.25

1.4

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.02

2.25

1.2

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

171

1.76

2.23

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1218

0.74

2.23

1.4

1.5

—

(3044009) aPTT.lupus sensitive (LA screen)

2.33

2.21

1.1

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

109

822

1.33

2.20

1.9

2.1

48.96

23.84

mg/l

1.80

207

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

110

831

1.33

2.19

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

234

1937

1.21

2.19

2.0

2.2

0.04

g/l

0.08

202

1768

(40768806) Pleura Pathology biopsy report

729

1.35

2.17

1.4

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1676

15726

1.08

2.17

1.3

1.54

1.93

u/ml

0.77

465

4110

(3024891) Influenza virus A+B Ag [Presence] in Specimen

235

1949

1.21

2.16

1.2

—

(3019174) dRVVT (LA screen)

2.30

2.14

1.1

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

298

1.55

2.12

1.2

—

(1002224) Polysomnography panel

236

2824

0.83

2.12

1.1

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1493

13957

1.08

2.12

1.5

2.35

2.39

g/l

0.23

897

8450

(3019897) Erythrocyte distribution width [Ratio] by Automated count

890

0.71

2.06

4.0

2.6

13.43

13.14

1.13

878

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

145

1149

1.27

2.04

1.2

1.1

7895.85

8248.11

iu/ml

0.01

290

(3034770) Mitochondria Ab [Titer] in Serum

231

1925

1.20

2.04

1.3

720.00

1027.82

titre

—

(3034426) Prothrombin time (PT)

246

1.59

2.03

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

132

1.82

2.02

1.1

0.77

0.69

umol/24h

0.30

(3022145) Colonoscopy Study observation

683

7544

0.90

2.02

1.3

1.4

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.11

2.01

1.0

0.00

0.66

u/ml

—

(3026389) Candida sp identified in Specimen by Organism specific culture

125

976

1.28

1.99

1.4

1.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

103

1340

0.77

1.98

1.1

3.06

2.32

u/ml

0.18

748

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

753

6845

1.11

1.98

4.0

4.1

14.11

27.71

ug/l

1.29

619

5568

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

284

2420

1.18

1.97

2.2

2.3

10.27

10.20

g/l

0.09

239

2150

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

216

1797

1.21

1.96

2.1

2.2

0.01

0.00

g/l

0.45

184

1636

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2277

23872

0.94

1.95

4.4

4.9

3.13

3.28

ug/l

0.12

2030

21433

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

177

1444

1.23

1.95

1.5

1.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.56

1.93

2.4

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.96

1.93

1.0

1.3

219.37

297.85

nmol/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

250

1.56

1.91

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

144

1152

1.25

1.90

1.7

1.6

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

397

1.44

1.89

1.1

0.13

10.83

nmol/l

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

100

764

1.31

1.89

1.3

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

237

1998

1.19

1.87

2.0

2.1

37.66

37.67

g/l

0.01

192

1742

(3026692) Albumin [Mass/volume] in Peritoneal fluid

166

1.69

1.86

1.3

1.5

11.85

13.68

g/l

0.41

130

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

457

1.40

1.86

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.65

1.86

1.1

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.86

1.86

1.0

1.6

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

354

0.56

1.83

1.3

1.4

24.48

32.68

nmol/l

0.66

312

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

253

1.54

1.83

1.2

1.1

—

(3022621) pH of Urine by Test strip

507

4531

1.13

1.82

3.5

2.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

459

1.40

1.82

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.12

1.81

6.2

9.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

168

1.67

1.79

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

255

1.53

1.77

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

166

1361

1.22

1.77

1.8

1.7

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

129

1605

0.80

1.76

1.2

1.1

2.07

2.47

u/ml

0.23

882

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1255

13375

0.93

1.72

1.6

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

372

1.43

1.72

1.4

1.5

6.28

7.79

ug/l

0.95

328

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

106

830

1.28

1.70

2.0

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

210

1770

1.19

1.70

2.1

2.2

0.00

g/l

-0.00

184

1632

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1073

0.76

1.69

1.1

2.00

3.94

u/ml

1.69

540

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

291

1.48

1.68

3.6

3.3

1.56

1.29

ug/l

0.30

272

(3002385) Erythrocyte distribution width [Ratio]

6212

61045

1.06

1.68

24.9

16.7

14.89

14.88

0.04

6143

59929

(3037522) Nuclear Ab [Titer] in Serum

1004

9332

1.09

1.67

1.4

1.3

527.41

529.65

titre

0.01

216

1878

(1617658) Protocol used for examination of sentinel lymph nodes

442

0.63

1.66

1.0

1.1

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.58

1.65

1.0

1.1

—

23.61

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.10

1.65

2.2

2.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.80

1.64

1.0

1.6

40.74

13.20

nmol/l

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

103

809

1.28

1.63

2.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

504

4541

1.12

1.61

1.2

89.51

143.85

iu/ml

3.36

193

1663

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

212

1802

1.18

1.58

1.9

2.0

11.71

11.37

mg/l

0.21

194

1678

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

312

1.44

1.58

1.1

92.73

93.35

0.04

241

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.00

1.58

1.0

1.4

—

mmol/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

321

1.43

1.56

1.3

1.6

1.62

5.74

nmol/l

1.87

255

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

492

1.34

1.53

2.2

1.6

29.89

22.95

u/ml

0.61

105

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

114

1411

0.81

1.52

1.9

1.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

122

987

1.24

1.52

1.4

1.5

0.32

0.38

nmol/l

0.52

782

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

623

1.30

1.52

1.3

1.4

—

(3016135) IgD [Mass/volume] in Serum

3.33

1.52

1.0

1.1

21.40

70.11

mg/l

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

266

1.47

1.50

1.2

1.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

908

8448

1.08

1.49

1.7

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1017

0.77

1.48

1.1

2.28

3.30

u/ml

0.71

462

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

155

1.61

1.46

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

179

1.57

1.45

1.2

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

252

1.47

1.44

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

266

0.56

1.44

1.0

1.2

11.14

17.13

u/ml

—

169

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

585

1.30

1.43

1.2

232.14

197.89

titre

0.15

114

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

585

1.30

1.43

1.2

1.3

—

150.00

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

150

1250

1.20

1.42

3.4

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

204

1.52

1.42

1.1

1.2

—

(3042631) Mycobacterium sp identified in Specimen

113

915

1.24

1.42

2.5

2.9

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

229

1.49

1.40

1.1

1.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.17

1.39

1.4

3.0

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

279

1.44

1.39

1.1

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

961

0.78

1.38

1.3

6.73

7.19

mmol/l

0.85

853

(3008116) Ketones [Moles/volume] in Urine by Test strip

142

1.62

1.37

1.4

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.00

1.37

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

150

1.60

1.37

1.4

2.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

643

1.28

1.36

1.3

1.4

5.88

6.40

mmol/l

1.37

595

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

127

1.65

1.36

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

127

1.65

1.36

1.1

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.94

1.36

1.0

2.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6549

66318

0.95

1.35

4.6

4.4

5.88

5.92

mmol/l

1.72

5989

60537

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

502

0.70

1.35

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.75

1.34

1.3

1.8

—

(3010375) cycloSPORINE [Mass/volume] in Blood

376

1.36

1.31

25.6

26.0

109.12

116.71

ug/l

0.40

313

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

895

0.78

1.28

1.6

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1997

20776

0.95

1.28

3.8

3.9

12.35

9.71

mg/mmol

1.15

1306

13436

(3000570) Elastase.pancreatic [Mass/mass] in Stool

230

2007

1.15

1.28

1.4

257.30

277.11

ug/g

0.79

134

1162

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

893

0.78

1.26

1.1

0.04

0.45

u/ml

3.14

292

(3008536) Aspergillus sp Ab [Presence] in Serum

138

1.60

1.25

3.0

2.3

—

(3044927) Protein electrophoresis panel - Urine

669

1.26

1.25

1.5

1.2

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

116

0.43

1.24

1.0

1.2

0.02

4.60

u/ml

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

236

1.44

1.24

1.1

1.2

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.86

1.23

3.7

3.4

0.81

1.42

mg/l

—

(3035880) pH of Pleural fluid

381

1.34

1.22

1.2

1.3

—

(3017704) Immunofixation for Urine

374

1.34

1.19

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

203

1767

1.15

1.19

5.3

4.1

—

(3003338) MCHC [Mass/volume]

6164

60776

1.05

1.18

28.1

17.7

334.33

332.77

g/l

32.37

6113

60259

(3030313) Adrenal Ab [Titer] in Serum

1.88

1.17

1.6

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

315

1.37

1.17

6.2

5.3

80.29

66.34

mg/l

0.74

224

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

771

0.78

1.17

1.1

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.70

1.17

1.4

1.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.93

1.16

1.4

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.50

1.15

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

121

1438

0.84

1.14

1.1

3.80

6.20

u/ml

1.58

805

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

220

2497

0.88

1.14

1.6

1.7

—

(3020491) Glucose [Moles/volume] in Blood

535

1.27

1.14

1.6

2.0

7.63

6.49

mmol/l

1.72

379

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1001

0.81

1.14

1.1

7.17

5.43

u/ml

0.23

437

(46235355) HIV 1 and 2 tests - Meaningful Use set

1410

13452

1.06

1.14

1.8

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

332

0.66

1.14

1.1

—

(4281824) Cell count and differential, peritoneal fluid

655

0.76

1.13

1.4

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

209

0.57

1.12

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

233

1.42

1.12

2.0

2.1

670.29

3897.86

e6/l

0.51

171

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

127

1.58

1.11

1.2

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

423

1.30

1.10

1.2

1.09

1.05

ratio

1.37

143

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.78

1.10

1.1

1.3

—

(40761536) Microorganisms panel - Urine sediment

643

5986

1.08

1.10

4.7

3.9

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

209

1.44

1.10

1.6

1.9

13508.90

15988.20

e6/l

0.07

122

(3010144) Erythrocytes [#/volume] in Synovial fluid

628

1.24

1.09

1.5

1.3

119014.41

113091.21

e6/l

0.03

430

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

226

1.42

1.09

1.1

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

422

0.71

1.09

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

118

1397

0.84

1.08

1.1

0.54

1.13

u/ml

2.11

679

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.95

1.08

1.0

1.1

—

(3025941) Bacteria identified in Stool by Culture

435

3988

1.10

1.07

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

470

1.28

1.06

1.8

1.5

70.38

83.14

umol/l

4.40

470

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

881

0.80

1.06

1.1

1.4

2.84

4.39

ug/l

2.13

790

(3020961) Endomysium IgA Ab [Titer] in Serum

382

3484

1.10

1.06

1.2

1.1

146.25

166.73

titre

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

129

1.55

1.05

1.1

—

(3044941) Cell count panel - Synovial fluid

1055

0.82

1.04

1.5

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

170

1.47

1.04

1.1

1.4

15.96

16.65

umol/l

0.27

154

(3009677) Dengue virus Ab [Presence] in Serum

2.27

1.03

1.0

1.1

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

148

0.54

1.03

1.1

11.29

54.36

u/ml

—

141

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

932

0.81

1.02

1.3

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.83

1.02

1.2

2.34

1.62

umol/24h

0.61

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

159

1825

0.87

1.01

1.5

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

310

0.68

1.00

1.8

1.5

5.33

4.06

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

194

1711

1.14

0.99

1.9

1.8

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.71

0.98

1.2

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

2.17

0.98

1.2

1.00

1.36

u/field

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

503

1.25

0.97

1.7

1.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.97

0.0

1.0

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

432

1.27

0.97

1.8

1.5

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

232

1.38

0.97

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

405

3727

1.09

0.95

1.8

1.9

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.89

0.94

1.1

1.4

22.40

24.12

pmol/l

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.77

0.94

1.0

1.1

—

(40768446) Kidney Pathology biopsy report

304

1.32

0.91

1.8

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

148

1292

1.15

0.90

3.6

3.1

0.73

0.83

nmol/l

3.21

111

970

(3000012) Reticulocyte production index

116

995

1.17

0.89

2.2

2.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

376

1.28

0.89

1.9

1.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6547

64784

1.04

0.89

19.0

13.1

86.68

82.02

ml/min/173m2

48.84

5592

53381

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

427

0.75

0.88

1.4

1.5

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

181

0.61

0.87

1.6

2.0

—

135.37

—

(21494890) Protein electrophoresis panel - 24 hour Urine

684

1.20

0.87

1.8

2.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.86

0.87

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

378

1.27

0.86

1.9

1.6

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.82

0.85

1.0

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

204

1.37

0.84

1.4

1.3

59.05

54.91

0.22

170

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

502

4690

1.07

0.84

1.8

2.0

—

(21494434) Karyotype in Bone marrow

596

1.21

0.83

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

265

1.32

0.83

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

265

1.32

0.83

2.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

113

0.53

0.82

1.0

1.1

0.02

8.66

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

345

1.28

0.82

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

345

1.28

0.82

2.0

—

(3000034) Microalbumin [Mass/volume] in Urine

655

0.81

3.4

3.1

92.23

56.67

mg/l

0.32

505

(3041096) Erythrocytes [Presence] in Urine by Automated

1919

18604

1.04

0.81

4.2

3.2

—

(3045414) Leukocytes [Presence] in Urine

334

3075

1.09

0.81

1.8

1.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

239

2166

1.11

0.81

4.9

5.9

1.52

1.45

mg/l

0.62

219

2011

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

553

1.21

0.81

2.0

1.5

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

535

1.22

0.80

1.1

1.0

284.72

283.45

mg/l

0.04

480

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

267

1.31

0.80

2.3

2.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

7832

78710

0.95

0.79

32.3

20.6

132.90

135.78

g/l

56.86

7748

77569

(3045142) Bone marrow Pathology biopsy report

775

1.18

0.79

1.3

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

268

1.31

0.78

1.1

1.0

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.67

0.78

1.0

2.6

—

76.90

—

(40768795) Lymph node Pathology biopsy report

651

0.81

0.78

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

350

0.74

0.78

5.5

4.1

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.77

0.0

1.1

—

0.21

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

132

1159

1.14

0.77

1.6

0.78

g/l

0.01

102

883

(3026361) Erythrocytes [#/volume] in Blood

7831

78692

0.95

0.77

32.1

20.5

4.39

4.51

e12/l

85.41

7675

76391

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

427

0.77

0.76

1.2

1.3

1.57

1.53

g/l

0.22

427

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

174

1939

0.89

0.75

1.1

4.34

7.09

u/ml

0.48

241

(3035320) C reactive protein [Mass/volume] in Body fluid

494

1.22

0.75

1.9

2.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

714

1.18

0.75

2.2

1.4

30.20

24.87

iu/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.69

0.75

1.0

1.1

—

(3035941) MCH [Entitic mass]

7830

78677

0.95

0.75

31.9

20.4

30.49

30.25

27.65

7746

77540

(3024731) MCV [Entitic volume]

7831

78681

0.95

0.74

32.0

20.4

91.07

90.72

9.01

7748

77543

(3026493) Urate [Moles/volume] in Serum or Plasma

1773

18256

0.96

0.73

2.9

2.7

3135.13

4306.16

umol/l

0.70

1535

16013

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

323

0.74

0.73

1.2

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

108

1.48

0.73

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

579

0.81

0.72

1.2

1.3

205.08

185.87

pmol/l

0.18

579

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.79

0.72

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.52

0.72

1.4

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

142

1.41

0.72

1.5

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.67

0.72

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.75

0.71

1.1

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

355

0.76

0.71

7.5

5.6

37.80

10016.04

u/ml

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.92

0.70

1.2

1.1

—

(40758358) Immune stain study

1.92

0.70

1.0

—

(3010813) Leukocytes [#/volume] in Blood

7834

78697

0.95

0.70

32.1

20.5

6.79

6.77

e9/l

0.31

7683

76368

(4146454) Self-monitoring of blood glucose

707

0.83

0.70

2.4

2.7

—

(40768793) Breast Pathology biopsy report

116

1317

0.88

0.70

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

795

1.16

0.69

1.4

1.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

619

1.18

0.69

1.5

1.3

1.52

1.46

nmol/l

0.18

555

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

849

8119

1.05

0.69

4.3

4.4

32.52

32.27

0.25

621

5635

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

152

1.38

0.68

1.1

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

314

2914

1.08

0.67

1.1

1.17

10.10

u/ml

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

465

1.21

0.67

1.1

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

938

9764

0.96

0.67

1.4

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

107

939

1.14

0.66

1.1

1.47

1.51

g/l

0.64

840

(3005322) IgE [Units/volume] in Serum or Plasma

473

4460

1.06

0.65

1.3

137.06

243.38

u/ml

5.67

432

4135

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

386

3617

1.07

0.64

2.4

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

201

0.70

0.64

1.0

19.75

11.68

u/ml

—

121

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

569

1.18

0.64

5.5

3.6

58.59

43.48

u/ml

0.25

564

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

395

1.22

0.63

1.4

3.0

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

112

1.43

0.63

1.6

1.7

93.27

148.92

ng/l

1.70

112

(3007461) Platelets [#/volume] in Blood

7830

78625

0.96

0.62

32.1

20.5

247.95

250.13

e9/l

2.10

7697

76541

(3004716) Salmonella sp identified in Stool by Organism specific culture

377

3537

1.07

0.61

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

147

1.36

0.61

1.0

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

368

0.79

0.61

2.0

133.29

176.92

ug/min

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.1

—

223.13

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

15.93

—

(3009542) Hematocrit [Volume Fraction] of Blood

7826

78576

0.96

0.59

32.2

20.6

39.38

40.44

15.09

7326

73699

(3034274) Bile acid [Moles/volume] in Serum --fasting

929

0.87

0.59

2.0

2.7

4.61

7.61

umol/l

2.24

687

(3003740) Influenza virus B Ag [Presence] in Specimen

103

1162

0.88

0.59

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

103

1162

0.88

0.59

1.1

—

(3012516) Albumin [Mass/volume] in Urine

1931

19762

0.97

0.57

3.3

599.18

397.09

mg/l

0.90

1313

12901

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

106

1.42

0.57

1.2

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

428

1.19

0.57

1.5

1.3

113.33

336.05

titre

—

(3019832) Treponema pallidum Ab [Presence] in Serum

671

7006

0.95

0.57

1.6

1.7

—

(3015183) Erythrocyte sedimentation rate

342

0.79

0.57

1.2

—

(36660697) Celiac disease serology panel - Serum

601

5735

1.05

0.56

1.2

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

0.57

0.56

1.0

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

424

4478

0.94

0.56

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.45

0.56

1.1

12.25

15.56

u/l

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

461

0.82

0.55

1.3

1.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

569

5428

1.05

0.55

1.5

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.58

0.54

1.0

1.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.58

0.54

1.0

1.7

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.48

0.53

1.7

1.6

53.11

43.13

umol/l

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

295

1.22

0.52

1.0

1.1

1.60

6.67

u/ml

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.52

0.52

1.2

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

271

0.77

0.52

1.5

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

619

1.15

0.52

4.5

4.9

137.33

62.76

u/ml

0.38

180

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

461

1.17

0.51

1.1

1.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

133

0.68

0.51

2.1

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

185

2004

0.92

0.51

1.4

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

360

1.19

0.51

1.4

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

360

1.19

0.51

1.4

1.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

462

1.17

0.50

1.2

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

135

1.33

0.50

1.1

1.2

1.76

1.64

mmol/l

0.20

(3047007) Chlamydophila sp Ab [Presence] in Serum

1031

0.89

0.50

1.3

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

214

2301

0.93

0.50

1.4

1.3

—

(4212803) Bone marrow aspirate examination

1.49

0.49

1.1

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

107

0.65

0.48

1.3

3.5

—

(3033799) Differential panel - Peritoneal fluid

208

1.25

0.47

2.3

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

147

1597

0.92

0.46

1.2

1.3

—

(3014891) Appearance of Pleural fluid

1.38

0.45

1.5

1.2

—

(3001556) Androgen free Index in Serum or Plasma

0.61

0.45

1.2

1.3

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

0.60

0.45

1.0

0.50

0.12

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

385

0.83

0.45

1.9

—

(3021788) Differential panel - Synovial fluid

110

1210

0.91

0.45

1.7

1.5

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.37

0.44

1.0

1.2

—

(3025130) Human papilloma virus identified in Specimen

798

0.89

0.43

1.6

1.7

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

744

1.12

0.42

1.3

0.40

g/l

0.03

527

(3027135) IgG subclass 1 [Mass/volume] in Serum

745

1.11

0.42

1.3

6.88

6.69

g/l

0.13

525

(3028192) IgG subclass 2 [Mass/volume] in Serum

745

1.11

0.42

1.3

2.92

2.90

g/l

0.03

528

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(44813793) Dust mix specific IgE antibody measurement

510

1.14

0.41

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4601

46414

0.98

0.40

3.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.40

0.0

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.39

0.40

2.0

4.5

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.47

0.40

1.0

1.1

—

(3007463) Buprenorphine [Presence] in Urine

1.43

0.39

3.4

5.8

—

(3022670) pH of Venous cord blood

1.43

0.39

1.0

1.1

—

(4062490) Immunoglobulin typing, IgG

749

1.11

0.39

1.4

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

368

3850

0.95

0.39

1.0

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.39

0.0

8.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

151

1.26

0.38

1.5

0.31

0.43

ug/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

419

1.15

0.38

1.5

1.6

7.21

6.82

u/l

0.09

340

(3006462) Nitrate [Presence] in Urine

335

1.16

0.38

2.3

3.5

—

(3049717) Cytology report of Urine Cyto stain

273

2589

1.06

0.38

2.3

2.8

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.29

0.36

1.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

122

1128

1.08

0.36

1.5

1.2

62.36

39.16

u/l

0.56

107

984

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

171

1.23

0.35

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

171

1.23

0.35

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

171

1.23

0.35

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

171

1.23

0.35

1.0

1.1

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

480

1.13

0.34

1.4

1.2

33.43

11.78

u/ml

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

172

1.22

0.34

1.4

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.68

0.33

15.5

7.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

501

1.12

0.32

1.3

1.2

66.00

74.26

u/ml

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

164

1.22

0.32

1.9

0.08

0.20

nmol/l

1.66

117

(3036071) Salmonella sp Ab [Titer] in Serum

238

1.18

0.32

1.0

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

172

1622

1.06

0.31

1.2

1.3

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

129

1206

1.07

0.30

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

322

3091

1.04

0.30

1.4

30.46

25.74

iu/l

1.51

263

2577

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

129

1.24

0.30

1.9

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

2148

21758

0.98

0.30

3.3

7.54

7.76

mmol/l

1.27

1833

18483

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

505

1.11

0.29

1.3

1.2

27.43

41.68

u/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

783

1.09

0.29

1.8

2.5

1.70

1.46

g/24h

0.30

395

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

639

1.10

0.29

3.0

3.6

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

130

0.77

0.29

1.0

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

535

0.90

0.29

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

179

1697

1.06

0.28

2.4

2.3

183.94

109.54

ug/min

1.23

1040

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.28

0.28

1.2

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

128

1361

0.94

0.28

1.3

1.2

59.78

39.13

u/ml

0.66

132

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

205

1.17

0.27

1.1

1.0

—

(3047189) Immunofixation for 24 hour Urine

321

0.87

0.26

1.2

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

166

1575

1.05

0.26

1.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

259

2488

1.04

0.25

1.2

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

181

0.83

0.25

3.7

3.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1127

11072

1.02

0.25

1.6

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

781

1.08

0.25

1.0

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

114

1.23

0.25

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

212

2212

0.96

0.24

1.5

1.6

21.18

4.52

iu/ml

0.44

475

(40761995) Spermatozoa Progressive [#/volume] in Semen

226

1.15

0.24

2.2

3.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

378

1.11

0.24

1.7

1.5

1.12

1.20

nmol/l

0.25

290

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

475

0.90

0.24

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

152

1.18

0.23

1.7

1.2

—

(40768443) Skin Pathology biopsy report

309

2988

1.03

0.23

1.2

—

(3024471) HLA-A [Type]

256

1.13

0.23

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

232

0.86

0.22

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

494

0.91

0.22

1.0

1.1

10.80

9.32

iu/ml

—

114

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.25

0.22

1.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

858

8735

0.98

0.22

2.1

2.5

152.42

132.42

ug/g

0.63

682

6956

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

839

8543

0.98

0.22

2.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

126

1195

1.05

0.22

1.1

—

(40765096) Chromosome analysis panel by Banding

210

0.86

0.22

1.2

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.19

0.21

1.0

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.8

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

12.62

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

163

1.17

0.21

1.3

1.1

20.46

20.16

mmol/l

0.09

145

(3018291) Platelet Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.21

0.0

1.2

—

70.69

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

7.0

—

0.27

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.21

0.0

1.2

—

37.23

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.4

—

(40768441) Liver Pathology biopsy report

517

1.08

0.21

1.6

1.5

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

177

0.85

0.21

6.3

6.9

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.2

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

7.9

—

60.60

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

249

2405

1.04

0.20

3.1

3.5

165.60

2710.90

u/ml

1.43

211

2054

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

112

0.80

0.20

1.1

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

202

1.14

0.20

1.3

1.2

38.47

38.64

g/l

0.02

112

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

268

2595

1.03

0.20

2.2

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

160

1534

1.04

0.19

1.2

1.4

261.53

259.08

u/ml

0.04

104

929

(3014051) Protein [Presence] in Urine by Test strip

176

1829

0.96

0.19

2.3

2.6

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

118

1.19

0.19

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

121

0.83

0.18

1.1

1.5

5.20

8.68

—

(3024932) HLA-DR beta [Type]

252

1.11

0.17

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

289

0.90

0.17

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

149

1432

1.04

0.17

1.5

1.6

103.05

114.04

u/ml

0.68

281

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.22

0.17

1.3

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.72

0.16

1.2

—

577.74

—

(3006270) Folate [Moles/volume] in Blood

611

1.06

0.16

1.1

1.2

312.04

358.33

nmol/l

1.18

513

(3042733) HLA Ab [Presence] in Serum

253

1.11

0.16

4.9

4.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

642

1.06

0.15

1.2

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.20

0.15

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

226

1.11

0.15

4.6

6.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

100

1044

0.96

0.15

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

166

1606

1.03

0.14

1.7

1.8

3.82

4.55

iu/l

0.50

580

(3044007) Cell count panel - Peritoneal fluid

188

1.12

0.14

1.5

2.0

—

(3025577) Chromium [Mass/volume] in Blood

399

0.93

0.14

2.0

2.1

4.07

2.41

ug/l

0.35

331

(3051387) C reactive protein [Mass/volume] in Capillary blood

147

1520

0.97

0.14

5.0

3.4

27.06

27.24

mg/l

0.02

954

(3000475) Leukocytes [#/volume] in Synovial fluid

168

1628

1.03

0.14

1.8

1.6

12410.35

14346.38

e6/l

0.35

120

1172

(3000330) Specific gravity of Urine by Test strip

355

3480

1.02

0.13

4.1

3.4

—

(3000285) Sodium [Moles/volume] in Blood

1.17

0.13

1.1

—

(3048879) Bone marrow aspiration report

190

0.89

0.13

2.1

1.8

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

123

1.14

0.12

1.1

—

5.23

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

425

1.06

0.11

1.4

1.5

10.95

6.34

u/l

0.44

366

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.15

0.10

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

197

0.91

0.10

6.3

6.9

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

203

1.08

0.09

1.7

2.6

271.75

117.61

ng/l

0.46

136

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

625

0.96

0.09

1.1

—

(40768797) Stomach Pathology biopsy report

934

9266

1.01

0.08

1.2

—

(3001729) Color of Synovial fluid

0.83

0.08

1.0

1.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

311

3065

1.01

0.08

3.2

3.4

134.91

56.52

u/ml

0.38

300

2957

(3016750) Collection duration of Urine

399

0.95

0.08

2.4

2.2

492.90

491.15

min

0.03

296

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

778

7714

1.01

0.08

2.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

127

1.10

0.07

6.6

7.7

—

(3035933) Granulocytes/100 leukocytes in Blood

266

0.94

0.07

1.5

1.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

140

1370

1.02

0.07

1.3

1.2

1.59

4.21

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

570

5749

0.99

0.07

2.2

12.40

12.56

nmol/l

0.16

498

5132

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.86

0.07

1.1

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.05

0.07

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.88

0.06

11.6

12.7

5.15

5.74

mmol/l

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

101

0.89

0.06

1.2

1.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

1.11

0.06

2.7

1.8

122.45

41.06

pmol/l

0.55

(40759836) Histone Ab [Presence] in Serum by Immunoblot

512

1.03

0.06

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

512

1.03

0.06

1.2

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

800

0.97

0.06

1.9

1.5

57.41

59.55

0.21

509

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

608

0.97

0.06

1.6

1.5

31.58

29.09

0.23

374

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

513

1.03

0.06

1.2

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

218

1.05

0.05

1.9

1.7

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

185

1826

1.01

0.05

1.3

1.2

53.08

36.75

u/ml

0.43

104

(3004775) Volume in Urine collected for unspecified duration

555

0.97

0.05

2.2

2.3

674.11

633.91

0.26

369

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

515

1.03

0.04

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

515

1.03

0.04

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

233

2354

0.99

0.04

1.6

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

225

2226

1.01

0.04

1.8

48.88

40.62

nmol/l

2.54

220

2158

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

160

1579

1.01

0.04

2.0

1.9

198.83

203.70

pmol/l

0.24

150

1488

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

516

1.03

0.04

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

121

1.07

0.03

1.5

1.4

—

(3002619) Bacteria identified in Specimen by Culture

149

0.94

0.03

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

169

1672

1.01

0.03

1.4

1.2

4.53

5.41

u/ml

0.13

160

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

161

1.06

0.03

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

399

1.03

0.03

6.5

6.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

310

0.97

0.03

1.2

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

390

0.97

0.03

1.2

1.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

521

1.02

0.02

1.2

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

117

0.94

0.02

6.6

6.9

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

140

1390

1.01

0.01

3.1

3.5

1058.17

694.27

u/ml

0.18

127

1274

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

218

2186

1.00

0.00

1.3

190.61

218.14

miu/ml

0.49

982

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

170

1693

1.00

0.00

1.4

1.3

19.30

8.46

u/ml

0.76

259

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

344

1.02

0.00

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

524

1.01

0.00

1.5

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

156

1565

1.00

0.00

1.2

—

(3006598) pH of Arterial cord blood

128

1.02

0.00

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

195

0.97

0.00

1.4

1.5

11.71

8.90

ug/l

0.88

195

(3022689) Creatine [Moles/volume] in Urine

207

1.01

0.00

1.7

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

197

1.01

0.00

2.0

1.7

—

(3020650) Glucose [Presence] in Urine

175

0.97

0.00

1.1

1.5

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

467

1.01

0.00

1.3

0.31

3.25

u/ml

4.97

259

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

144

0.97

0.00

1.0

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

144

1437

1.00

0.00

2.0

0.89

0.80

nmol/l

0.73

117

1200

(3024263) Appearance of Synovial fluid

369

1.00

0.00

1.2

1.4

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

145

0.97

0.00

5.1

6.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.96

0.00

1.1

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.02

-0.00

5.0

4.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

5.3

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.04

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.93

-0.00

1.0

165.40

165.28

g/l

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(3027859) Formaldehyde IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.91

-0.00

1.6

1.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.86

-0.00

1.8

4.8

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

-0.00

0.0

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

20.84

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: FE_MODE – Focal epilepsy, mode (most common among epilepsy diagnosis)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Focal epilepsy, mode (most common among epilepsy diagnosis)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Focal epilepsy, mode (most common among epilepsy diagnosis) (FE_MODE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints